

<!-- RR Donnelley Xcelerate Instance Document, based on XBRL 2.1  http://www.edgar-online.com/ -->
<!-- Version:  6.20.1 -->
<!-- Round: 5 -->
<!-- Creation date: 2013-03-27T21:39:15Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:mnov="http://www.medicinova.com/20121231" xmlns:us-types="http://fasb.org/us-types/2012-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2012-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2012-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:utr="http://www.xbrl.org/2009/utr">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="mnov-20121231.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <mnov:CommonStockOutstandingPercentage contextRef="eol_PE402953--1210-K0005_STD_0_20050228_0" unitRef="pure" decimals="2" id="id_1125627_9A7C7312-1C28-4273-B2ED-ECF9314C5543_1_1">0.03</mnov:CommonStockOutstandingPercentage>
  <mnov:IncreaseInNumberOfSharesAvailableForIssuanceUnderIncentivePlan contextRef="eol_PE402953--1210-K0005_STD_0_20050228_0" unitRef="shares" decimals="0" id="id_1125627_9A7C7312-1C28-4273-B2ED-ECF9314C5543_1_0">100000</mnov:IncreaseInNumberOfSharesAvailableForIssuanceUnderIncentivePlan>
  <us-gaap:SharePrice contextRef="eol_PE402953--1210-K0005_STD_0_20070201_0_501891x497488_512768x505027" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_122A4A9B-F9E1-4277-9C72-D10CC1583D35_1002_1">12.00</us-gaap:SharePrice>
  <us-gaap:CommonStockValue contextRef="eol_PE402953--1210-K0005_STD_0_20110505_0_514782x597451" unitRef="iso4217_USD" decimals="-5" id="id_1125627_34104C8C-6B70-4A64-B730-B3D42DBFE8FA_1001_0">15000000</us-gaap:CommonStockValue>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE402953--1210-K0005_STD_0_20120822_0" unitRef="shares" decimals="0" id="id_1125627_DE935CB2-5A6E-41A3-8B5D-9C41B3DE6775_1002_0">130000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <mnov:ClassOfWarrantOrRightFairValue contextRef="eol_PE402953--1210-K0005_STD_0_20120822_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE935CB2-5A6E-41A3-8B5D-9C41B3DE6775_1002_4">100000</mnov:ClassOfWarrantOrRightFairValue>
  <mnov:ClassOfWarrantsOrRightsExercisePriceOfWarrantsOrRights contextRef="eol_PE402953--1210-K0005_STD_0_20120822_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_DE935CB2-5A6E-41A3-8B5D-9C41B3DE6775_1002_1">1.88</mnov:ClassOfWarrantsOrRightsExercisePriceOfWarrantsOrRights>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="eol_PE402953--1210-K0005_STD_0_20120331_0" unitRef="pure" decimals="2" id="id_1125627_803AED89-4310-4A46-B83C-484A8A1020DC_1001_1">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <mnov:EquityMethodInvestmentThirdPartyPercentage contextRef="eol_PE402953--1210-K0005_STD_0_20120331_0" unitRef="pure" decimals="2" id="id_1125627_803AED89-4310-4A46-B83C-484A8A1020DC_1001_2">0.70</mnov:EquityMethodInvestmentThirdPartyPercentage>
  <dei:EntityCommonStockSharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20130327_0" unitRef="shares" decimals="INF" id="id_1125627_FB236EEF-BFE5-4EA6-9963-433DC44C83C8_2_500008">18244502</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE402953--1210-K0005_STD_0_20100531_0" unitRef="pure" decimals="4" id="id_1125627_E80F7E11-E81E-4121-ABA9-214C32B253E7_1001_2">0.1287</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE402953--1210-K0005_STD_0_20100531_0" unitRef="iso4217_USD" decimals="-5" id="id_1125627_E80F7E11-E81E-4121-ABA9-214C32B253E7_1001_1">15000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE402953--1210-K0005_STD_0_20100531_0" unitRef="shares" decimals="0" id="id_1125627_E48FB803-3D2A-45B6-905D-CD34CF227C67_2_0">198020</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE402953--1210-K0005_STD_0_20100531_0" unitRef="iso4217_USD_per_shares" decimals="3" id="id_1125627_E48FB803-3D2A-45B6-905D-CD34CF227C67_2_1">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE402953--1210-K0005_STD_0_20100531_0" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1125627_E48FB803-3D2A-45B6-905D-CD34CF227C67_2_2">6.06</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE402953--1210-K0005_STD_0_20100531_0_497730x537055_501883x507828" unitRef="shares" decimals="0" id="id_1125627_216B67E9-BCB8-44CE-ABE6-689AEFCB9B59_1001_0">198020</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <mnov:ClassOfWarrantsOrRightsExercisePriceOfWarrantsOrRights contextRef="eol_PE402953--1210-K0005_STD_0_20100531_0_497730x629508_501883x507828" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_216B67E9-BCB8-44CE-ABE6-689AEFCB9B59_2001_1">6.06</mnov:ClassOfWarrantsOrRightsExercisePriceOfWarrantsOrRights>
  <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="eol_PE402953--1210-K0005_STD_0_20110618_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_F308FC51-9146-461C-B295-EEE3F6177891_1_0">6.80</us-gaap:DebtInstrumentConvertibleConversionPrice1>
  <dei:EntityPublicFloat contextRef="eol_PE402953--1210-K0005_STD_0_20120629_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_FB236EEF-BFE5-4EA6-9963-433DC44C83C8_3_600009">22014000</dei:EntityPublicFloat>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE402953--1210-K0005_STD_0_20000930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_F8378E1D-C03E-4580-97C3-33D9F5317ACA_1_0">10.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <mnov:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAnnualVestingPercentage contextRef="eol_PE402953--1210-K0005_STD_0_20000930_0" unitRef="pure" decimals="2" id="id_1125627_F8378E1D-C03E-4580-97C3-33D9F5317ACA_1_1">0.25</mnov:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAnnualVestingPercentage>
  <us-gaap:SharePrice contextRef="eol_PE402953--1210-K0005_STD_0_20040902_0_513696x506792" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_440ADF3F-4B9E-4CDA-A10D-15BB59685F6E_1002_1">1.62</us-gaap:SharePrice>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20091231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_27010_1300091">40013474</us-gaap:StockholdersEquity>
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="eol_PE402953--1210-K0005_STD_0_20091231_0_499577x629064" unitRef="pure" decimals="2" id="id_1125627_73A85632-5F3A-4766-815B-AD5299EB3892_2001_0">1.00</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20091231_0_505872x500724" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_27007_1000091">-64914</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20091231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_27003_700091">12170</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20091231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_27003_600091">12172510</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20091231_0_505872x502884" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_27008_1100091">-1235395</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20091231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_27009_1200091">-247351099</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20091231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_27005_800091">288652712</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_29010_1300101">24704360</us-gaap:StockholdersEquity>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE402953--1210-K0005_STD_0_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3001_36">28252204</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE402953--1210-K0005_STD_0_20101231_0_497966x503003" unitRef="iso4217_USD" decimals="0" id="id_1125627_82FE3EB1-31B7-40DD-8321-BBA3C0560A52_1003_1">15134491</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE402953--1210-K0005_STD_0_20101231_0_497966x503003_503845x507708" unitRef="iso4217_USD" decimals="0" id="id_1125627_82FE3EB1-31B7-40DD-8321-BBA3C0560A52_1001_1">15000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE402953--1210-K0005_STD_0_20101231_0_497966x503003_503845x598913" unitRef="iso4217_USD" decimals="0" id="id_1125627_82FE3EB1-31B7-40DD-8321-BBA3C0560A52_1002_1">134491</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:UnamortizedDebtIssuanceExpense contextRef="eol_PE402953--1210-K0005_STD_0_20101231_0_497966x534321" unitRef="iso4217_USD" decimals="0" id="id_1125627_374F0890-CE80-4BB6-92C0-7B2DA7BDBE0B_1001_1">124722</us-gaap:UnamortizedDebtIssuanceExpense>
  <us-gaap:UnamortizedDebtIssuanceExpense contextRef="eol_PE402953--1210-K0005_STD_0_20101231_0_497966x678600" unitRef="iso4217_USD" decimals="0" id="id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_1003_1">699276</us-gaap:UnamortizedDebtIssuanceExpense>
  <us-gaap:UnamortizedDebtIssuanceExpense contextRef="eol_PE402953--1210-K0005_STD_0_20101231_0_497966x678600_503845x532020" unitRef="iso4217_USD" decimals="0" id="id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_1002_1">103934</us-gaap:UnamortizedDebtIssuanceExpense>
  <us-gaap:UnamortizedDebtIssuanceExpense contextRef="eol_PE402953--1210-K0005_STD_0_20101231_0_497966x678600_511283x507958" unitRef="iso4217_USD" decimals="0" id="id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_1001_1">595342</us-gaap:UnamortizedDebtIssuanceExpense>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20101231_0_505872x500724" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_29007_1000101">-55702</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20101231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_29003_700101">12484</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20101231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_29003_600101">12482867</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20101231_0_505872x502884" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_29008_1100101">-1197935</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20101231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_29009_1200101">-267538407</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20101231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_29005_800101">293483920</us-gaap:StockholdersEquity>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion contextRef="eol_PE402953--1210-K0005_STD_0_20111031_0_629552x629554" unitRef="shares" decimals="INF" id="id_1125627_E5A6F4BE-C282-4DCE-83D2-4A6C01D3606F_5001_9">10</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="eol_PE402953--1210-K0005_STD_0_20111031_0_629552x629554" unitRef="pure" decimals="2" id="id_1125627_E5A6F4BE-C282-4DCE-83D2-4A6C01D3606F_5001_7">0.03</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE402953--1210-K0005_STD_0_20111031_0_629552x629554" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_E5A6F4BE-C282-4DCE-83D2-4A6C01D3606F_5001_6">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE402953--1210-K0005_STD_0_20111031_0_629552x629554" unitRef="iso4217_USD_per_shares" decimals="3" id="id_1125627_E5A6F4BE-C282-4DCE-83D2-4A6C01D3606F_5001_3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <mnov:ClassOfWarrantOrRightExpirationPeriod contextRef="eol_PE402953--1210-K0005_STD_0_20120831_0" id="id_1125627_DE935CB2-5A6E-41A3-8B5D-9C41B3DE6775_1001_3">P5Y</mnov:ClassOfWarrantOrRightExpirationPeriod>
  <mnov:OtherAssetAmortizationPeriod contextRef="eol_PE402953--1210-K0005_STD_0_20120831_0" id="id_1125627_DE935CB2-5A6E-41A3-8B5D-9C41B3DE6775_1001_5">P1Y</mnov:OtherAssetAmortizationPeriod>
  <mnov:StockPurchaseAgreementNumberOfSharesCanBePurchasedPerDay contextRef="eol_PE402953--1210-K0005_STD_0_20120831_0_497730x544104_504957x514053_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_8001_5">50000</mnov:StockPurchaseAgreementNumberOfSharesCanBePurchasedPerDay>
  <mnov:StockPurchaseAgreementValueOfSharesCanBePurchasedPerDay contextRef="eol_PE402953--1210-K0005_STD_0_20120831_0_497730x544104_504957x514053_505872x501348" unitRef="iso4217_USD" decimals="INF" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_8001_6">500000</mnov:StockPurchaseAgreementValueOfSharesCanBePurchasedPerDay>
  <mnov:VolumeWeightedAveragePurchaseAsPercentageOfAggregateSharesOfStockTradedNextBusinessDay contextRef="eol_PE402953--1210-K0005_STD_0_20120831_0_497730x544104_504957x514053_505872x501348_629552x629554" unitRef="pure" decimals="2" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_9001_10">0.30</mnov:VolumeWeightedAveragePurchaseAsPercentageOfAggregateSharesOfStockTradedNextBusinessDay>
  <us-gaap:CommonStockSharesSubscriptions contextRef="eol_PE402953--1210-K0005_STD_0_20120831_0_497730x544104_504957x514053_629552x629554" unitRef="iso4217_USD" decimals="-6" id="id_1125627_91FFC9CD-8939-485C-8AD5-0E7C93C65A18_5003_4">20000000</us-gaap:CommonStockSharesSubscriptions>
  <us-gaap:CommonStockSharesSubscriptions contextRef="eol_PE402953--1210-K0005_STD_0_20120831_0_497730x544104_505872x501348_629552x629554" unitRef="iso4217_USD" decimals="-6" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_10001_0">20000000</us-gaap:CommonStockSharesSubscriptions>
  <mnov:VolumeWeightedAveragePurchaseAsPercentageOfAggregateSharesOfStockTradedNextBusinessDay contextRef="eol_PE402953--1210-K0005_STD_0_20120831_0_497730x544104_505872x501348_629552x629554" unitRef="pure" decimals="2" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_10001_9">0.15</mnov:VolumeWeightedAveragePurchaseAsPercentageOfAggregateSharesOfStockTradedNextBusinessDay>
  <mnov:VolumeWeightedAveragePurchaseAsPercentageOfNextBusinessDayNasdaqVolumeWeightedAveragePrice contextRef="eol_PE402953--1210-K0005_STD_0_20120831_0_497730x544104_505872x501348_629552x629554" unitRef="pure" decimals="2" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_10001_11">0.95</mnov:VolumeWeightedAveragePurchaseAsPercentageOfNextBusinessDayNasdaqVolumeWeightedAveragePrice>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20001231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_1010_1300006">4848675</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20001231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_1003_700006">50</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20001231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_1003_600006">50000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20001231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_1009_1200006">-201325</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20001231_0_505872x503547" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_1001_500006">5000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20001231_0_505872x503547" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_1001_400006">500000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20001231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_1005_800006">5044950</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20011231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_4010_1300010">8053941</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20011231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_4003_700010">50</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20011231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_4003_600010">50000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20011231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_4009_1200010">-1996059</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20011231_0_505872x503547" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_4001_500010">10000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20011231_0_505872x503547" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_4001_400010">1000000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20011231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_4005_800010">10039950</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20021231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_7010_1300012">1122465</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20021231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_7003_700012">50</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20021231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_7003_600012">50000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20021231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_7009_1200012">-8927535</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20021231_0_505872x503547" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_7001_500012">10000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20021231_0_505872x503547" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_7001_400012">1000000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20021231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_7005_800012">10039950</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20031231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_9010_1300017">4569882</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20031231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_9003_700017">50</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20031231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_9003_600017">50000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20031231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_9009_1200017">-15136665</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20031231_0_505872x503547" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_9001_500017">11075</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20031231_0_505872x503547" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_9001_400017">1107500</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20031231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_9005_800017">19695422</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20041231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_12010_1300027">7669122</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20041231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_12003_700027">50</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20041231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_12003_600027">50000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20041231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_12009_1200027">-94752701</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20041231_0_505872x503547" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_12001_500027">12912</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20041231_0_505872x503547" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_12001_400027">1291150</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20041231_0_505872x508051" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_12006_900027">-1194721</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20041231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_12005_800027">103603582</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20051231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_16010_1300046">135707779</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20051231_0_505872x500724" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_16007_1000046">-15188</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20051231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_16003_700046">9885</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20051231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_16003_600046">9885585</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20051231_0_505872x502884" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_16008_1100046">-55445</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20051231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_16009_1200046">-120464525</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20051231_0_505872x508051" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_16006_900046">-799439</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20051231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_16005_800046">257032491</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20061231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_19010_1300064">100980908</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20061231_0_505872x500724" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_19007_1000064">-49205</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20061231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_19003_700064">10422</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20061231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_19003_600064">10421985</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20061231_0_505872x502884" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_19008_1100064">-1437870</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20061231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_19009_1200064">-156154136</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20061231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_19005_800064">258611697</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20071231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_23010_1300076">66608201</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20071231_0_505872x500724" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_23007_1000076">-131466</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20071231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_23003_700076">12072</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20071231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_23003_600076">12072027</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20071231_0_505872x502884" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_23008_1100076">-1404088</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20071231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_23009_1200076">-205057380</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20071231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_23005_800076">273189063</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="eol_PE402953--1210-K0005_STD_0_20071231_0_512768x509009" unitRef="shares" decimals="INF" id="id_1125627_138D4C3E-4542-4C5D-B278-E8E3750A099C_1001_0">300000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20081231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_25010_1300083">48044532</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20081231_0_505872x500724" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_25007_1000083">-29744</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20081231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_25003_700083">12072</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20081231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_25003_600083">12072027</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20081231_0_505872x502884" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_25008_1100083">-1317362</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20081231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_25009_1200083">-226982209</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20081231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_25005_800083">276361775</us-gaap:StockholdersEquity>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE402953--1210-K0005_STD_0_20110323_0" unitRef="iso4217_USD_per_Right" decimals="2" id="id_1125627_0D67167D-1A4C-49BE-8565-09E034C33BC2_1_5">3.56</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <mnov:ConsistsOfEachFirmCommitmentUnderwrittenPublicOfferingUnit contextRef="eol_PE402953--1210-K0005_STD_0_20110323_0" id="id_1125627_0D67167D-1A4C-49BE-8565-09E034C33BC2_1_3">One share of common stock, and a warrant  to purchase one share of common stock.</mnov:ConsistsOfEachFirmCommitmentUnderwrittenPublicOfferingUnit>
  <mnov:FirmCommitmentUnderwrittenPublicOfferingGrossAmount contextRef="eol_PE402953--1210-K0005_STD_0_20110323_0" unitRef="iso4217_USD" decimals="-4" id="id_1125627_0D67167D-1A4C-49BE-8565-09E034C33BC2_1_2">8250000</mnov:FirmCommitmentUnderwrittenPublicOfferingGrossAmount>
  <mnov:FirmCommitmentUnderwrittenPublicOfferingPrice contextRef="eol_PE402953--1210-K0005_STD_0_20110323_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_0D67167D-1A4C-49BE-8565-09E034C33BC2_1_1">3.00</mnov:FirmCommitmentUnderwrittenPublicOfferingPrice>
  <mnov:NumberOfUnitsInFirmCommitmentUnderwrittenPublicOffering contextRef="eol_PE402953--1210-K0005_STD_0_20110323_0" unitRef="shares" decimals="0" id="id_1125627_0D67167D-1A4C-49BE-8565-09E034C33BC2_1_0">2750000</mnov:NumberOfUnitsInFirmCommitmentUnderwrittenPublicOffering>
  <mnov:NumberOfUnitsOverAllotted contextRef="eol_PE402953--1210-K0005_STD_0_20110324_0" unitRef="shares" decimals="0" id="id_1125627_0D67167D-1A4C-49BE-8565-09E034C33BC2_3_7">412500</mnov:NumberOfUnitsOverAllotted>
  <mnov:NumberOfUnitsUnderwriterExercised contextRef="eol_PE402953--1210-K0005_STD_0_20110324_0" unitRef="shares" decimals="0" id="id_1125627_0D67167D-1A4C-49BE-8565-09E034C33BC2_3_6">50666</mnov:NumberOfUnitsUnderwriterExercised>
  <mnov:WaivedOffPenaltyPaymentAmount contextRef="eol_PE402953--1210-K0005_STD_0_20110331_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A96F8A2B-9117-44B4-93F7-3A59382AAEA1_1_0">437000</mnov:WaivedOffPenaltyPaymentAmount>
  <mnov:BusinessAcquisitionCostOfAcquiredEntitySecuredConvertibleNotesIssuedConversionPricePerShare contextRef="eol_PE402953--1210-K0005_STD_0_20110331_0_499577x629064" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_73A85632-5F3A-4766-815B-AD5299EB3892_2003_3">6.80</mnov:BusinessAcquisitionCostOfAcquiredEntitySecuredConvertibleNotesIssuedConversionPricePerShare>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_3">614540</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:Goodwill contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_5">9600241</us-gaap:Goodwill>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_AE850F9C-3E30-4001-8E48-673B5A3C5AA2_1002_3">955360</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:DeferredTaxAssetsNet contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_2_10">87833000</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_2_11">89789000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_2_12">-1956000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_2_3">7124000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_35">23497546</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_27">30000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_14">599087</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:CapitalizedComputerSoftwareGross contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_AE850F9C-3E30-4001-8E48-673B5A3C5AA2_1002_2">221380</us-gaap:CapitalizedComputerSoftwareGross>
  <us-gaap:TreasuryStockShares contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_33">39600</us-gaap:TreasuryStockShares>
  <us-gaap:DeferredTaxLiabilities contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_2_9">1956000</us-gaap:DeferredTaxLiabilities>
  <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_2_8">1956000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_29">16088015</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_2_4">395000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
  <us-gaap:Liabilities contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_19">7289784</us-gaap:Liabilities>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_12">718882</us-gaap:AccountsPayableCurrent>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_2_1">79215000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredRevenueCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_15">863510</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DeferredTaxAssetsOther contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_2_5">988000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_23">500000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_34">-285272483</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:Assets contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_9">30787330</us-gaap:Assets>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_1B7DF365-A773-4CE7-A051-E989B735835D_2001_1">5.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_17">1956000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_22">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_36">30787330</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LeaseholdImprovementsGross contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_AE850F9C-3E30-4001-8E48-673B5A3C5AA2_1002_0">172648</us-gaap:LeaseholdImprovementsGross>
  <us-gaap:TreasuryStockValue contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_32">1189705</us-gaap:TreasuryStockValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_2">15093124</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_28">16127615</us-gaap:CommonStockSharesIssued>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_31">-56845</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_13">1515815</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:FurnitureAndFixturesGross contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_AE850F9C-3E30-4001-8E48-673B5A3C5AA2_1002_1">561332</us-gaap:FurnitureAndFixturesGross>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_16">3697294</us-gaap:LiabilitiesCurrent>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1125627_A04B885A-CC41-4E32-89D8-6A45B0C3A08F_2001_400001">3092671</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:CommonStockValue contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_25">16128</us-gaap:CommonStockValue>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_26">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:DeferredRevenueNoncurrent contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_18">1636490</us-gaap:DeferredRevenueNoncurrent>
  <us-gaap:AssetsCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_4">15707664</us-gaap:AssetsCurrent>
  <us-gaap:DeferredTaxAssetsGross contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_2_6">89789000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="shares" decimals="INF" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_24">220000</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockValue contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_21">2200</us-gaap:PreferredStockValue>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_AE850F9C-3E30-4001-8E48-673B5A3C5AA2_1002_4">925935</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_8">29425</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_7">650000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
  <us-gaap:AdditionalPaidInCapital contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_30">309998251</us-gaap:AdditionalPaidInCapital>
  <mnov:DeferredTaxAssetsCapitalizedExpenses contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_2_2">2067000</mnov:DeferredTaxAssetsCapitalizedExpenses>
  <mnov:AccruedExpense contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_76314746-038F-48B4-BD16-6555C881C5DD_2_4">1515815</mnov:AccruedExpense>
  <mnov:InProcessResearchAndDevelopment contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_2_6">4800000</mnov:InProcessResearchAndDevelopment>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0_497966x504935" unitRef="iso4217_USD" decimals="0" id="id_1125627_76314746-038F-48B4-BD16-6555C881C5DD_1002_3">149200</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0_497966x506779" unitRef="iso4217_USD" decimals="0" id="id_1125627_76314746-038F-48B4-BD16-6555C881C5DD_2002_0">615792</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0_497966x514038" unitRef="iso4217_USD" decimals="0" id="id_1125627_76314746-038F-48B4-BD16-6555C881C5DD_3002_1">100823</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0_497966x629304" unitRef="iso4217_USD" decimals="0" id="id_1125627_76314746-038F-48B4-BD16-6555C881C5DD_4002_2">650000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0_498503x502717" unitRef="iso4217_USD" decimals="0" id="id_1125627_53BA69D5-7722-4F3F-A837-518C7D318335_1001_2">1690</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0_498503x502717_510142x508799" unitRef="iso4217_USD" decimals="0" id="id_1125627_53BA69D5-7722-4F3F-A837-518C7D318335_1002_2">1690</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0_505872x500724" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_31007_1000119">-56845</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_31003_700119">16128</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_31003_600119">16127615</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0_505872x502884" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_31008_1100119">-1189705</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_31009_1200119">-285272483</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0_505872x503547" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_31001_500119">2200</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0_505872x503547" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_31001_400119">220000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_31005_800119">309998251</us-gaap:StockholdersEquity>
  <mnov:PreferredStockPricePerShare contextRef="eol_PE402953--1210-K0005_STD_0_20111231_0_507189x534959" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_32010_1300109">3.00</mnov:PreferredStockPricePerShare>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_3">411592</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:Goodwill contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_5">9600241</us-gaap:Goodwill>
  <us-gaap:CashFDICInsuredAmount contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_9082C287-7B74-470A-95E5-8298D0EFD8F7_1001_0">250000</us-gaap:CashFDICInsuredAmount>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_AE850F9C-3E30-4001-8E48-673B5A3C5AA2_1001_3">750775</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:DeferredTaxAssetsNet contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_1_10">92226000</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_1_11">94182000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_1_12">-1956000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_A04B885A-CC41-4E32-89D8-6A45B0C3A08F_1001_400006">2089963</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_1_3">7145000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:StockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_35">14879992</us-gaap:StockholdersEquity>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_1125627_2F7ACEEA-E2F2-46CD-9D48-3B9AE82E6610_2_0">1000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_27">100000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_14">228124</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:CapitalizedComputerSoftwareGross contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_AE850F9C-3E30-4001-8E48-673B5A3C5AA2_1001_2">228397</us-gaap:CapitalizedComputerSoftwareGross>
  <us-gaap:TreasuryStockShares contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_33">4186</us-gaap:TreasuryStockShares>
  <us-gaap:DeferredTaxLiabilities contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_1_9">1956000</us-gaap:DeferredTaxLiabilities>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_1B7DF365-A773-4CE7-A051-E989B735835D_1001_6">6.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_1_8">1956000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_29">17403125</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_1_4">570000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DBB8FCF7-8914-48D7-99C6-FCBD37822629_1001_0">77039</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:Liabilities contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_19">4688049</us-gaap:Liabilities>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_12">491853</us-gaap:AccountsPayableCurrent>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_1_1">83783000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredRevenueCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_15">3163</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DeferredTaxAssetsOther contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_1_5">862000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_23">3000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_34">-296233797</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:Assets contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_9">19568041</us-gaap:Assets>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_1B7DF365-A773-4CE7-A051-E989B735835D_1001_5">4.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_17">1956000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_22">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_36">19568041</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LeaseholdImprovementsGross contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_AE850F9C-3E30-4001-8E48-673B5A3C5AA2_1001_0">170386</us-gaap:LeaseholdImprovementsGross>
  <us-gaap:TreasuryStockValue contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_32">1131086</us-gaap:TreasuryStockValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_2">4010530</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_28">17407311</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_36010_1300128">14879922</us-gaap:CommonStockholdersEquity>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_31">-67957</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_580BE352-E861-4092-8FAD-EAF89444FE0C_1001_4">7173997</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_13">314652</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:FurnitureAndFixturesGross contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_AE850F9C-3E30-4001-8E48-673B5A3C5AA2_1001_1">351992</us-gaap:FurnitureAndFixturesGross>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_16">1037792</us-gaap:LiabilitiesCurrent>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_A04B885A-CC41-4E32-89D8-6A45B0C3A08F_1001_400005">3328981</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:CommonStockValue contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_25">17407</us-gaap:CommonStockValue>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_26">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:DeferredRevenueNoncurrent contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_18">1694257</us-gaap:DeferredRevenueNoncurrent>
  <us-gaap:AssetsCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_4">4422122</us-gaap:AssetsCurrent>
  <us-gaap:DeferredTaxAssetsGross contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_1_6">94182000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_24">220000</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockValue contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_21">2200</us-gaap:PreferredStockValue>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DBB8FCF7-8914-48D7-99C6-FCBD37822629_1001_1">77039</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_AE850F9C-3E30-4001-8E48-673B5A3C5AA2_1001_4">672301</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_8">78474</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_7">667204</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
  <us-gaap:AdditionalPaidInCapital contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_30">312293225</us-gaap:AdditionalPaidInCapital>
  <mnov:WorkingCapitalNet contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_1125627_F10691A0-DBEA-4946-9E8B-0CAFFEED76FF_1001_1">3400000</mnov:WorkingCapitalNet>
  <mnov:TaxCreditCarryforwardLimitation contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-6" id="id_1125627_C74877CB-0CEF-436D-910F-31BB6156EF02_1_3">1000000</mnov:TaxCreditCarryforwardLimitation>
  <mnov:AnnualLimitationOfNetOperatingLossCarryforwards contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_1125627_C74877CB-0CEF-436D-910F-31BB6156EF02_1_2">7300000</mnov:AnnualLimitationOfNetOperatingLossCarryforwards>
  <mnov:DeferredTaxAssetsCapitalizedExpenses contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_A045204B-9EFF-41DB-A36F-D6B244F7B42B_1_2">1822000</mnov:DeferredTaxAssetsCapitalizedExpenses>
  <mnov:AccruedExpense contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_76314746-038F-48B4-BD16-6555C881C5DD_1_4">314652</mnov:AccruedExpense>
  <mnov:InProcessResearchAndDevelopment contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_DE83A70D-68EC-4815-A1FB-F867668E7BE7_1_6">4800000</mnov:InProcessResearchAndDevelopment>
  <mnov:MaturityPeriodOfInvestmentInCashEquivalentsSecurities contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0" id="id_1125627_6D59C5CD-6D3F-4F91-8A5E-1EC8AE4E66D3_1_0">Three  months or less</mnov:MaturityPeriodOfInvestmentInCashEquivalentsSecurities>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_497966x504935" unitRef="iso4217_USD" decimals="0" id="id_1125627_76314746-038F-48B4-BD16-6555C881C5DD_1001_3">94504</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_497966x506779" unitRef="iso4217_USD" decimals="0" id="id_1125627_76314746-038F-48B4-BD16-6555C881C5DD_2001_0">152046</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_497966x514038" unitRef="iso4217_USD" decimals="0" id="id_1125627_76314746-038F-48B4-BD16-6555C881C5DD_3001_1">68102</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_498429x586825" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_C8308DEB-F7F1-4BE5-B193-BCF4FA870A7A_1001_1">10.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_498429x586825" unitRef="shares" decimals="INF" id="id_1125627_C8308DEB-F7F1-4BE5-B193-BCF4FA870A7A_1001_0">4000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_498503x502717" unitRef="iso4217_USD" decimals="0" id="id_1125627_53BA69D5-7722-4F3F-A837-518C7D318335_3001_1">1720</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_498503x502717_510142x508799" unitRef="iso4217_USD" decimals="0" id="id_1125627_53BA69D5-7722-4F3F-A837-518C7D318335_3002_1">1720</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:OtherCommitment contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_501050x510280" unitRef="iso4217_USD" decimals="-5" id="id_1125627_0C761BC2-ECC9-4F76-B32B-34BD2F5F318D_1002_1">94100000</us-gaap:OtherCommitment>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_505769x507958" unitRef="shares" decimals="INF" id="id_1125627_580BE352-E861-4092-8FAD-EAF89444FE0C_2001_1">3128686</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_505872x500724" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_36007_1000128">-67957</us-gaap:CommonStockholdersEquity>
  <us-gaap:CommonStockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_505872x501348" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_36003_700128">17407</us-gaap:CommonStockholdersEquity>
  <mnov:SharesCommonStockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_36003_600128">17407311</mnov:SharesCommonStockholdersEquity>
  <us-gaap:CommonStockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_505872x502884" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_36008_1100128">-1131086</us-gaap:CommonStockholdersEquity>
  <us-gaap:CommonStockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_505872x503287" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_36009_1200128">-296233797</us-gaap:CommonStockholdersEquity>
  <us-gaap:CommonStockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_505872x503547" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_36001_500128">2200</us-gaap:CommonStockholdersEquity>
  <mnov:SharesCommonStockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_505872x503547" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_36001_400128">220000</mnov:SharesCommonStockholdersEquity>
  <us-gaap:CommonStockholdersEquity contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_36005_800128">312293225</us-gaap:CommonStockholdersEquity>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_508454x511626" unitRef="shares" decimals="INF" id="id_1125627_580BE352-E861-4092-8FAD-EAF89444FE0C_3001_2">3328981</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_508454x517939" unitRef="shares" decimals="INF" id="id_1125627_580BE352-E861-4092-8FAD-EAF89444FE0C_4001_3">466752</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:OperatingLossCarryforwards contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_508681x532681" unitRef="iso4217_USD" decimals="-5" id="id_1125627_1F055DDA-8FA7-4AD5-8091-C582F63323EE_1001_0">205700000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:TaxCreditCarryforwardAmount contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_508681x532681" unitRef="iso4217_USD" decimals="-5" id="id_1125627_1F055DDA-8FA7-4AD5-8091-C582F63323EE_1001_2">6200000</us-gaap:TaxCreditCarryforwardAmount>
  <us-gaap:OperatingLossCarryforwards contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_508681x534951" unitRef="iso4217_USD" decimals="-5" id="id_1125627_1F055DDA-8FA7-4AD5-8091-C582F63323EE_2001_1">205100000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:TaxCreditCarryforwardAmount contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_508681x534951" unitRef="iso4217_USD" decimals="-5" id="id_1125627_1F055DDA-8FA7-4AD5-8091-C582F63323EE_2001_3">1400000</us-gaap:TaxCreditCarryforwardAmount>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_509470x506023" unitRef="iso4217_USD" decimals="-5" id="id_1125627_D12F1687-1ECB-4F98-8389-E5EBAFF33D69_1001_0">29400000</us-gaap:DebtInstrumentFaceAmount>
  <mnov:ClassOfWarrantOrRightFairValue contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_511283x507958" unitRef="iso4217_USD" decimals="2" id="id_1125627_64B758A5-DA4C-4FA6-ADA9-EE90E668106E_2001_4">4.34</mnov:ClassOfWarrantOrRightFairValue>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="eol_PE402953--1210-K0005_STD_0_20121231_0_512768x509009" unitRef="shares" decimals="INF" id="id_1125627_580BE352-E861-4092-8FAD-EAF89444FE0C_5001_0">249578</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE402953--1210-K0005_STD_20_20050228_0" id="id_1125627_CD5FCE6F-BE01-4982-A524-137814B8ECBB_1_0">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <mnov:TerminationPeriod contextRef="eol_PE402953--1210-K0005_STD_20_20050228_0" id="id_1125627_80F6CB2A-CA7B-4DC1-AABE-82AB045609E4_1_0">P10Y</mnov:TerminationPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE402953--1210-K0005_STD_20_20050228_0_501891x497548" unitRef="shares" decimals="INF" id="id_1125627_9F5744D2-AEAD-4203-9BEC-F8A0C04D968E_1001_4">6678285</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_20_20050228_0_501891x497548_512768x505027" unitRef="iso4217_USD" decimals="0" id="id_1125627_9F5744D2-AEAD-4203-9BEC-F8A0C04D968E_2001_1">104486895</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE402953--1210-K0005_STD_20_20050228_0_501891x497548_512768x505027" unitRef="shares" decimals="INF" id="id_1125627_9F5744D2-AEAD-4203-9BEC-F8A0C04D968E_2001_0">3000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <mnov:ExercisePriceAsPercentageOfFairMarketValueOfUnderlyingShares contextRef="eol_PE402953--1210-K0005_STD_20_20050228_0_508454x533445" unitRef="pure" decimals="2" id="id_1125627_CD5FCE6F-BE01-4982-A524-137814B8ECBB_1001_1">1.00</mnov:ExercisePriceAsPercentageOfFairMarketValueOfUnderlyingShares>
  <mnov:ExercisePriceAsPercentageOfFairMarketValueOfUnderlyingShares contextRef="eol_PE402953--1210-K0005_STD_20_20050228_0_508454x536875" unitRef="pure" decimals="2" id="id_1125627_CD5FCE6F-BE01-4982-A524-137814B8ECBB_2001_2">0.85</mnov:ExercisePriceAsPercentageOfFairMarketValueOfUnderlyingShares>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="eol_PE402953--1210-K0005_STD_27_20070228_0" unitRef="shares" decimals="INF" id="id_1125627_9A7C7312-1C28-4273-B2ED-ECF9314C5543_2_2">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_27_20070228_0_501891x497488_512768x505027" unitRef="iso4217_USD" decimals="0" id="id_1125627_122A4A9B-F9E1-4277-9C72-D10CC1583D35_1001_2">10639600</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE402953--1210-K0005_STD_27_20070228_0_501891x497488_512768x505027" unitRef="shares" decimals="INF" id="id_1125627_122A4A9B-F9E1-4277-9C72-D10CC1583D35_1001_0">1000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:OperatingLeasesRentExpenseMinimumRentals contextRef="eol_PE402953--1210-K0005_STD_28_20130228_0_506663x533051" unitRef="iso4217_USD" decimals="0" id="id_1125627_BCA62C9E-5DD9-4A66-9FF2-8D9C7F6CCD60_1001_2">10699</us-gaap:OperatingLeasesRentExpenseMinimumRentals>
  <mnov:SubleaseTerm contextRef="eol_PE402953--1210-K0005_STD_28_20130228_0_506663x533051" id="id_1125627_BCA62C9E-5DD9-4A66-9FF2-8D9C7F6CCD60_1001_1">P4Y9M</mnov:SubleaseTerm>
  <mnov:SubleaseCommencementDate contextRef="eol_PE402953--1210-K0005_STD_28_20130228_0_506663x533051" id="id_1125627_BCA62C9E-5DD9-4A66-9FF2-8D9C7F6CCD60_1001_0">2013-03-01</mnov:SubleaseCommencementDate>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE402953--1210-K0005_STD_28_20040930_0_513696x506792" unitRef="shares" decimals="INF" id="id_1125627_440ADF3F-4B9E-4CDA-A10D-15BB59685F6E_1001_0">27667856</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="eol_PE402953--1210-K0005_STD_28_20040930_0_513696x506792" unitRef="iso4217_USD" decimals="0" id="id_1125627_440ADF3F-4B9E-4CDA-A10D-15BB59685F6E_1001_2">43404320</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <mnov:DeemedDividendsOnPreferredStock contextRef="eol_PE402953--1210-K0005_STD_28_20040930_0_513696x506792" unitRef="iso4217_USD" decimals="0" id="id_1125627_440ADF3F-4B9E-4CDA-A10D-15BB59685F6E_1001_3">31264677</mnov:DeemedDividendsOnPreferredStock>
  <mnov:LeaseExpirationMonthAndYear contextRef="eol_PE402953--1210-K0005_STD_30_20050630_0_501891x497548" id="id_1125627_2AA75423-F9FE-4E73-B9CE-71D153C7A917_5_4">2013-05</mnov:LeaseExpirationMonthAndYear>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="eol_PE402953--1210-K0005_STD_30_20080630_0" unitRef="shares" decimals="INF" id="id_1125627_9A7C7312-1C28-4273-B2ED-ECF9314C5543_3_2">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
  <mnov:ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodOfTimeOptionsBecomeExercisable contextRef="eol_PE402953--1210-K0005_STD_30_20000930_0" id="id_1125627_840B0CE9-6C88-452A-B79C-C03268869E00_1_1">P10Y</mnov:ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodOfTimeOptionsBecomeExercisable>
  <mnov:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestingPeriod contextRef="eol_PE402953--1210-K0005_STD_30_20000930_0" id="id_1125627_F8378E1D-C03E-4580-97C3-33D9F5317ACA_2_2">P36M</mnov:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestingPeriod>
  <mnov:ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodAfterTerminationDateDuringWhichVestedOptionsCanBeExercisable contextRef="eol_PE402953--1210-K0005_STD_30_20000930_0" id="id_1125627_840B0CE9-6C88-452A-B79C-C03268869E00_1_0">P90D</mnov:ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodAfterTerminationDateDuringWhichVestedOptionsCanBeExercisable>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_31_20050331_0_501891x497548_512768x586108" unitRef="iso4217_USD" decimals="0" id="id_1125627_9F5744D2-AEAD-4203-9BEC-F8A0C04D968E_3002_3">5557773</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE402953--1210-K0005_STD_31_20050331_0_501891x497548_512768x586108" unitRef="shares" decimals="INF" id="id_1125627_9F5744D2-AEAD-4203-9BEC-F8A0C04D968E_3002_2">157300</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates contextRef="eol_PE402953--1210-K0005_STD_31_20120331_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_803AED89-4310-4A46-B83C-484A8A1020DC_1_0">680000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
  <us-gaap:LeaseExpirationDate1 contextRef="eol_PE402953--1210-K0005_STD_31_20120331_0_501891x543711" id="id_1125627_2AA75423-F9FE-4E73-B9CE-71D153C7A917_2_2">2013-02-28</us-gaap:LeaseExpirationDate1>
  <us-gaap:LeaseAndRentalExpense contextRef="eol_PE402953--1210-K0005_STD_31_20120331_0_501891x543711" unitRef="iso4217_USD" decimals="0" id="id_1125627_2AA75423-F9FE-4E73-B9CE-71D153C7A917_2_3">12672</us-gaap:LeaseAndRentalExpense>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE402953--1210-K0005_STD_31_20130331_0_497730x544104_505872x501348_506663x510886_629552x629554" unitRef="shares" decimals="0" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_4004_18">800000</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE402953--1210-K0005_STD_31_20130331_0_497730x544104_506663x510886_513696x501348_629552x629554" unitRef="shares" decimals="0" id="id_1125627_91FFC9CD-8939-485C-8AD5-0E7C93C65A18_1002_2">800000</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_31_20130331_0_497730x544104_506663x510886_629552x629554" unitRef="iso4217_USD" decimals="-5" id="id_1125627_91FFC9CD-8939-485C-8AD5-0E7C93C65A18_2002_1">1500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <mnov:WarrantsExpirationDate contextRef="eol_PE402953--1210-K0005_STD_31_20100531_0" id="id_1125627_E48FB803-3D2A-45B6-905D-CD34CF227C67_1_3">10-May-17</mnov:WarrantsExpirationDate>
  <mnov:DebtInstrumentAgreementDate contextRef="eol_PE402953--1210-K0005_STD_31_20100531_0" id="id_1125627_E80F7E11-E81E-4121-ABA9-214C32B253E7_2_0">May 2010</mnov:DebtInstrumentAgreementDate>
  <us-gaap:LeaseAndRentalExpense contextRef="eol_PE402953--1210-K0005_STD_31_20110731_0_501891x543711" unitRef="iso4217_USD" decimals="0" id="id_1125627_2AA75423-F9FE-4E73-B9CE-71D153C7A917_3_0">12468</us-gaap:LeaseAndRentalExpense>
  <mnov:LeaseExtensionPeriod contextRef="eol_PE402953--1210-K0005_STD_31_20110731_0_501891x543711" id="id_1125627_2AA75423-F9FE-4E73-B9CE-71D153C7A917_3_1">P9M</mnov:LeaseExtensionPeriod>
  <mnov:BusinessAcquisitionCostOfAcquiredEntityCashPaidPerShareHeld contextRef="eol_PE402953--1210-K0005_STD_31_20091231_0_499577x629064" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_73A85632-5F3A-4766-815B-AD5299EB3892_1001_2">1.19</mnov:BusinessAcquisitionCostOfAcquiredEntityCashPaidPerShareHeld>
  <mnov:PercentageOfShareholdersCashReceived contextRef="eol_PE402953--1210-K0005_STD_31_20091231_0_499577x629064" unitRef="pure" decimals="2" id="id_1125627_73A85632-5F3A-4766-815B-AD5299EB3892_1001_1">0.17</mnov:PercentageOfShareholdersCashReceived>
  <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned contextRef="eol_PE402953--1210-K0005_STD_31_20111031_0" unitRef="iso4217_USD" decimals="-5" id="id_1125627_2F6BD9AD-AA6C-4417-B102-3F4FC8DBFF32_1_1">2500000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
  <mnov:UpfrontPaymentRelatedToResearchAndDevelopmentServices contextRef="eol_PE402953--1210-K0005_STD_31_20111031_0" unitRef="iso4217_USD" decimals="-5" id="id_1125627_2F6BD9AD-AA6C-4417-B102-3F4FC8DBFF32_1_0">2500000</mnov:UpfrontPaymentRelatedToResearchAndDevelopmentServices>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE402953--1210-K0005_STD_31_20111031_0_505872x501348" unitRef="shares" decimals="0" id="id_1125627_E5A6F4BE-C282-4DCE-83D2-4A6C01D3606F_1001_2">800000</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE402953--1210-K0005_STD_31_20111031_0_505872x501348" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_E5A6F4BE-C282-4DCE-83D2-4A6C01D3606F_1001_5">2.50</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE402953--1210-K0005_STD_31_20111031_0_505872x501348_629552x629554" unitRef="shares" decimals="0" id="id_1125627_ECBE6169-0490-45D5-B3B5-F83BC73E193B_1001_1">800000</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE402953--1210-K0005_STD_31_20111031_0_513696x511225" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_E5A6F4BE-C282-4DCE-83D2-4A6C01D3606F_2001_4">25.00</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE402953--1210-K0005_STD_31_20111031_0_513696x511225_629552x629554" unitRef="shares" decimals="0" id="id_1125627_E5A6F4BE-C282-4DCE-83D2-4A6C01D3606F_3001_1">220000</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE402953--1210-K0005_STD_31_20111031_0_629552x629554" unitRef="iso4217_USD" decimals="-5" id="id_1125627_E5A6F4BE-C282-4DCE-83D2-4A6C01D3606F_4001_0">7500000</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:ConvertiblePreferredStockTermsOfConversion contextRef="eol_PE402953--1210-K0005_STD_31_20111031_0_629552x629554" id="id_1125627_E5A6F4BE-C282-4DCE-83D2-4A6C01D3606F_4001_8">Each share of the Series B Preferred is  convertible into 10 shares of common stock.</us-gaap:ConvertiblePreferredStockTermsOfConversion>
  <mnov:ClassOfWarrantOrRightsExercisablePeriodFromDateOfIssuance contextRef="eol_PE402953--1210-K0005_STD_31_20120831_0" id="id_1125627_DE935CB2-5A6E-41A3-8B5D-9C41B3DE6775_1_2">P15M</mnov:ClassOfWarrantOrRightsExercisablePeriodFromDateOfIssuance>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_31_20120831_0_497730x544104_505872x501348_629552x629554" unitRef="iso4217_USD" decimals="-6" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_5001_1">1000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE402953--1210-K0005_STD_31_20120831_0_497730x544104_505872x501348_629552x629554" unitRef="shares" decimals="0" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_5001_12">363636</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <mnov:SaleDurationForCommonStockUnderPurchaseAgreement contextRef="eol_PE402953--1210-K0005_STD_31_20120831_0_497730x544104_505872x501348_629552x629554" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_5001_4">P2Y</mnov:SaleDurationForCommonStockUnderPurchaseAgreement>
  <mnov:NumberOfConsecutiveBusinessDay contextRef="eol_PE402953--1210-K0005_STD_31_20120831_0_497730x544104_505872x501348_629552x629554" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_5001_8">P12D</mnov:NumberOfConsecutiveBusinessDay>
  <mnov:StockSubscriptionAgreementMaximumNumberOfShares contextRef="eol_PE402953--1210-K0005_STD_31_20120831_0_497730x544104_505872x501348_629552x629554" unitRef="shares" decimals="0" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_5001_2">3231096</mnov:StockSubscriptionAgreementMaximumNumberOfShares>
  <mnov:NumberOfLowestClosingStockPrices contextRef="eol_PE402953--1210-K0005_STD_31_20120831_0_497730x544104_505872x501348_629552x629554" unitRef="pure" decimals="0" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_5001_7">3</mnov:NumberOfLowestClosingStockPrices>
  <mnov:StockSubscriptionAgreementMaximumNumberOfShares contextRef="eol_PE402953--1210-K0005_STD_31_20120831_0_497730x544104_513696x501348_629552x629554" unitRef="shares" decimals="0" id="id_1125627_91FFC9CD-8939-485C-8AD5-0E7C93C65A18_3003_3">3231096</mnov:StockSubscriptionAgreementMaximumNumberOfShares>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="eol_PE402953--1210-K0005_STD_31_20110331_0" unitRef="iso4217_USD" decimals="-5" id="id_1125627_0D67167D-1A4C-49BE-8565-09E034C33BC2_2_8">7700000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <mnov:ExercisePeriodOfWarrants contextRef="eol_PE402953--1210-K0005_STD_31_20110331_0" id="id_1125627_0D67167D-1A4C-49BE-8565-09E034C33BC2_2_4">P5Y</mnov:ExercisePeriodOfWarrants>
  <mnov:BusinessAcquisitionCostOfAcquiredEntityCashPaidPerShareHeld contextRef="eol_PE402953--1210-K0005_STD_31_20110331_0_499577x629064" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_73A85632-5F3A-4766-815B-AD5299EB3892_1003_4">0.02</mnov:BusinessAcquisitionCostOfAcquiredEntityCashPaidPerShareHeld>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE402953--1210-K0005_STD_31_20121231_0_497730x544104_504957x513639_505872x501348_629552x629554" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_1002_13">1.65</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE402953--1210-K0005_STD_31_20121231_0_497730x544104_504957x514053_505872x501348_629552x629554" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_2002_14">1.93</us-gaap:EquityIssuancePerShareAmount>
  <mnov:ClosingPriceOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_31_20121231_0_497730x544104_504957x514053_629552x629554" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_3002_19">1.00</mnov:ClosingPriceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_31_20121231_0_497730x544104_505872x501348_629552x629554" unitRef="iso4217_USD" decimals="-5" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_5002_15">1500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE402953--1210-K0005_STD_31_20121231_0_497730x544104_505872x501348_629552x629554" unitRef="shares" decimals="0" id="id_1125627_6EC670C9-48AB-4A95-90C8-C8028F9976D3_5002_12">856060</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_365_20091231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_28010_1300087">81967</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20091231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_28010_1300085">406357</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20091231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_28010_1300090">-35170</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_365_20091231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_28010_1300089">-20368890</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20091231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_28010_1300084">2371636</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <mnov:AdjustmentsToAdditionalPaidInCapitalFairValueOfRedemptionFeatureOfPurchaseOfBusinessCombination contextRef="eol_PE402953--1210-K0005_STD_365_20091231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_28010_1300086">9513042</mnov:AdjustmentsToAdditionalPaidInCapitalFairValueOfRedemptionFeatureOfPurchaseOfBusinessCombination>
  <mnov:AverageValueOfSharesIssuedUnderEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_365_20091231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_28010_1300088">2.21</mnov:AverageValueOfSharesIssuedUnderEmployeeStockPurchasePlan>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20091231_0_505872x500724" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_28007_1000090">-35170</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20091231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_28003_600085">100483</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20091231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_28003_700085">98</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_365_20091231_0_505872x502884" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_28008_1100087">81967</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_365_20091231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_28009_1200089">-20368890</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20091231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_28005_800085">406259</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20091231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_28005_800084">2371636</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <mnov:AdjustmentsToAdditionalPaidInCapitalFairValueOfRedemptionFeatureOfPurchaseOfBusinessCombination contextRef="eol_PE402953--1210-K0005_STD_365_20091231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_28005_800086">9513042</mnov:AdjustmentsToAdditionalPaidInCapitalFairValueOfRedemptionFeatureOfPurchaseOfBusinessCombination>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30010_1300096">859208</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30010_1300095">1804780</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30010_1300097">37460</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30010_1300093">166599</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30010_1300100">9212</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30010_1300099">-20187308</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30010_1300092">2000935</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <mnov:AverageValueOfSharesIssuedUnderEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30010_1300098">6.56</mnov:AverageValueOfSharesIssuedUnderEmployeeStockPurchasePlan>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x500724" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30007_1000100">9212</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30003_600094">265409</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30003_600093">44948</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x501348" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30003_700095">265</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30003_700093">49</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x502884" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30008_1100097">37460</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30009_1200099">-20187308</us-gaap:NetIncomeLoss>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30005_800096">859208</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x508619" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30005_800095">1804515</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30005_800093">166550</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_30005_800092">2000935</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20011231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_5010_1300009">-1794734</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20011231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_5009_1200009">-1794734</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20011231_0_505872x503547_513696x498640" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_6001_500007">5000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20011231_0_505872x503547_513696x498640" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_6001_400007">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20011231_0_505872x508619_513696x498640" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_6005_800007">4995000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20011231_0_513696x498640" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_6010_1300007">5000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <mnov:PreferredStockIssuanceDollarAmountPerShare contextRef="eol_PE402953--1210-K0005_STD_365_20011231_0_513696x498640" unitRef="iso4217_USD_per_shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_6010_1300008">10</mnov:PreferredStockIssuanceDollarAmountPerShare>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20021231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_8010_1300011">-6931476</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20021231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_8009_1200011">-6931476</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20031231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_10010_1300016">-6209130</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20031231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_10009_1200016">-6209130</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20031231_0_505872x503547_513696x511225" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_11001_500013">1075</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20031231_0_505872x503547_513696x511225" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_11001_400013">107500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20031231_0_505872x508619_513696x511225" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_11005_800013">9655472</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20031231_0_513696x511225" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_11010_1300013">9656547</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE402953--1210-K0005_STD_365_20031231_0_513696x511225" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_11010_1300015">1093453</us-gaap:PaymentsOfStockIssuanceCosts>
  <mnov:PreferredStockIssuanceDollarAmountPerShare contextRef="eol_PE402953--1210-K0005_STD_365_20031231_0_513696x511225" unitRef="iso4217_USD_per_shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_11010_1300014">100</mnov:PreferredStockIssuanceDollarAmountPerShare>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17010_1300042">55445</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17010_1300031">5557773</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17010_1300045">-15188</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17010_1300044">-25692135</us-gaap:NetIncomeLoss>
  <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17010_1300041">19689</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
  <mnov:AmortizationOfDeferredEmployeeStockBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17010_1300039">311282</mnov:AmortizationOfDeferredEmployeeStockBasedCompensation>
  <mnov:ConversionOfRedeemableConvertiblePreferredStockIntoCommonStock contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17010_1300035">43502765</mnov:ConversionOfRedeemableConvertiblePreferredStockIntoCommonStock>
  <mnov:IssuanceCostsForRegistration contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17010_1300033">165476</mnov:IssuanceCostsForRegistration>
  <mnov:IssuanceOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17010_1300032">38.80</mnov:IssuanceOfCommonStock>
  <mnov:StockBasedCompensationOptionVestingAccelerationAndReissuanceOfOptions contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17010_1300038">127875</mnov:StockBasedCompensationOptionVestingAccelerationAndReissuanceOfOptions>
  <mnov:TreasuryStockDollarAmountPerShare contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17010_1300043">11.10</mnov:TreasuryStockDollarAmountPerShare>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x500724" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17007_1000045">-15188</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17003_600031">157300</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17003_700031">157</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <mnov:ConversionOfConvertiblePreferredStockIntoCommonStock contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17003_700037">3911</mnov:ConversionOfConvertiblePreferredStockIntoCommonStock>
  <mnov:ConversionOfConvertiblePreferredStockIntoCommonStockShares contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x501348" unitRef="shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17003_600036">-3911500</mnov:ConversionOfConvertiblePreferredStockIntoCommonStockShares>
  <mnov:ConversionOfRedeemableConvertiblePreferredStockIntoCommonStock contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17003_700035">2767</mnov:ConversionOfRedeemableConvertiblePreferredStockIntoCommonStock>
  <mnov:ConversionOfRedeemableConvertiblePreferredStockIntoCommonStockShares contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x501348" unitRef="shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17003_600034">2766785</mnov:ConversionOfRedeemableConvertiblePreferredStockIntoCommonStockShares>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x501348_512768x505027" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_18003_700029">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <mnov:IssuanceOfCommonStockInInitialPublicOfferingShares contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x501348_512768x505027" unitRef="shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_18003_600028">3000000</mnov:IssuanceOfCommonStockInInitialPublicOfferingShares>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x502884" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17008_1100042">55445</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17009_1200044">-25692135</us-gaap:NetIncomeLoss>
  <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x503287" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17009_1200041">19689</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
  <mnov:ConversionOfConvertiblePreferredStockIntoCommonStock contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x503547" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17001_500037">-12912</mnov:ConversionOfConvertiblePreferredStockIntoCommonStock>
  <mnov:ConversionOfConvertiblePreferredStockIntoCommonStockShares contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x503547" unitRef="shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17001_400036">1291150</mnov:ConversionOfConvertiblePreferredStockIntoCommonStockShares>
  <mnov:AmortizationOfDeferredEmployeeStockBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x508051" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17006_900039">311282</mnov:AmortizationOfDeferredEmployeeStockBasedCompensation>
  <mnov:CancelationOfStockOptionsIssuedToEmployees contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x508051" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17006_900040">-84000</mnov:CancelationOfStockOptionsIssuedToEmployees>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17005_800031">5557616</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <mnov:CancelationOfStockOptionsIssuedToEmployees contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17005_800040">84000</mnov:CancelationOfStockOptionsIssuedToEmployees>
  <mnov:ConversionOfConvertiblePreferredStockIntoCommonStock contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17005_800037">9001</mnov:ConversionOfConvertiblePreferredStockIntoCommonStock>
  <mnov:ConversionOfRedeemableConvertiblePreferredStockIntoCommonStock contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17005_800035">43499998</mnov:ConversionOfRedeemableConvertiblePreferredStockIntoCommonStock>
  <mnov:IssuanceCostsForRegistration contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17005_800033">165476</mnov:IssuanceCostsForRegistration>
  <mnov:StockBasedCompensationOptionVestingAccelerationAndReissuanceOfOptions contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_17005_800038">127875</mnov:StockBasedCompensationOptionVestingAccelerationAndReissuanceOfOptions>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x508619_512768x505027" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_18005_800029">104483895</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_512768x505027" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_18010_1300029">104486895</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE402953--1210-K0005_STD_365_20051231_0_512768x505027" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_18010_1300030">38.80</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20010_1300056">1400</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20010_1300059">1382425</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20010_1300055">14000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20010_1300063">-34017</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20010_1300062">-35689611</us-gaap:NetIncomeLoss>
  <mnov:AmortizationOfDeferredEmployeeStockBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20010_1300058">2090182</mnov:AmortizationOfDeferredEmployeeStockBasedCompensation>
  <mnov:CashlessWarrantExercisesShares contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0" unitRef="shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20010_1300049">260000</mnov:CashlessWarrantExercisesShares>
  <mnov:OptionExercisedDollarAmountPerShare contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20010_1300057">10.00</mnov:OptionExercisedDollarAmountPerShare>
  <mnov:WarrantExercisedDollarAmountPerShare contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20010_1300053">1.00</mnov:WarrantExercisedDollarAmountPerShare>
  <mnov:WarrantExercises contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20010_1300051">275000</mnov:WarrantExercises>
  <mnov:WarrantExercisesShares contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0" unitRef="shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20010_1300052">275000</mnov:WarrantExercisesShares>
  <mnov:TreasuryStockDollarAmountPerShare contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_504957x513639" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_21010_1300060">10.30</mnov:TreasuryStockDollarAmountPerShare>
  <mnov:TreasuryStockDollarAmountPerShare contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_504957x514053" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_22010_1300061">13.10</mnov:TreasuryStockDollarAmountPerShare>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x500724" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20007_1000063">-34017</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20003_600055">1400</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20003_700055">2</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <mnov:CashlessWarrantExercises contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20003_700048">260</mnov:CashlessWarrantExercises>
  <mnov:CashlessWarrantExercisesShares contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x501348" unitRef="shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20003_600047">260000</mnov:CashlessWarrantExercisesShares>
  <mnov:WarrantExercises contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20003_700051">275</mnov:WarrantExercises>
  <mnov:WarrantExercisesShares contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x501348" unitRef="shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20003_600050">275000</mnov:WarrantExercisesShares>
  <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x502884" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20008_1100059">1382425</us-gaap:TreasuryStockValueAcquiredCostMethod>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20009_1200062">-35689611</us-gaap:NetIncomeLoss>
  <mnov:EmployeeStockBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x508051" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20006_900054">799439</mnov:EmployeeStockBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20005_800055">13998</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <mnov:AmortizationOfDeferredEmployeeStockBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20005_800058">2090182</mnov:AmortizationOfDeferredEmployeeStockBasedCompensation>
  <mnov:CashlessWarrantExercises contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20005_800048">-260</mnov:CashlessWarrantExercises>
  <mnov:EmployeeStockBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20005_800054">-799439</mnov:EmployeeStockBasedCompensation>
  <mnov:WarrantExercises contextRef="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_20005_800051">274725</mnov:WarrantExercises>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24010_1300072">33782</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24010_1300069">10639600</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24010_1300075">-82261</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24010_1300074">-48903244</us-gaap:NetIncomeLoss>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24010_1300070">12.00</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24010_1300071">3939416</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <mnov:EmployeeStockPurchasePlanOfferingPeriod contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0" unitRef="M" decimals="0" id="id_1125627_138D4C3E-4542-4C5D-B278-E8E3750A099C_2_4">6</mnov:EmployeeStockPurchasePlanOfferingPeriod>
  <mnov:AverageValueOfSharesIssuedUnderEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24010_1300073">6.72</mnov:AverageValueOfSharesIssuedUnderEmployeeStockPurchasePlan>
  <mnov:CashlessWarrantExercisesShares contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0" unitRef="shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24010_1300067">650047</mnov:CashlessWarrantExercisesShares>
  <mnov:CommonStockFairMarketValuePercentage contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0" unitRef="pure" decimals="2" id="id_1125627_138D4C3E-4542-4C5D-B278-E8E3750A099C_2_3">0.85</mnov:CommonStockFairMarketValuePercentage>
  <mnov:PercentageOfEmployeeCompensationForPurchaseOfCommonStockUnderEspp contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0" id="id_1125627_138D4C3E-4542-4C5D-B278-E8E3750A099C_2_2">Cannot exceed 15%</mnov:PercentageOfEmployeeCompensationForPurchaseOfCommonStockUnderEspp>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0_505872x500724" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24007_1000075">-82261</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24003_700069">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <mnov:CashlessWarrantExercises contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24003_700066">650</mnov:CashlessWarrantExercises>
  <mnov:CashlessWarrantExercisesShares contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0_505872x501348" unitRef="shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24003_600065">650047</mnov:CashlessWarrantExercisesShares>
  <mnov:IssuanceOfCommonStockInPublicOfferingShares contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0_505872x501348" unitRef="shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24003_600068">1000000</mnov:IssuanceOfCommonStockInPublicOfferingShares>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0_505872x502884" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24008_1100072">33782</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24009_1200074">-48903244</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24005_800069">10638600</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24005_800071">3939416</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <mnov:CashlessWarrantExercises contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_24005_800066">-650</mnov:CashlessWarrantExercises>
  <us-gaap:EmployeeStockOwnershipPlanESOPPlanDescription contextRef="eol_PE402953--1210-K0005_STD_365_20071231_0_512768x509009" id="id_1125627_138D4C3E-4542-4C5D-B278-E8E3750A099C_1002_1">Shares reserved will automatically increase by a number equal to the lesser of  (i) 15,000 shares, (ii) 1% of the outstanding shares of our common stock on the  last day of the immediately preceding fiscal year or</us-gaap:EmployeeStockOwnershipPlanESOPPlanDescription>
  <mnov:BusinessAcquisitionCostOfAcquiredEntityCashPaidPerShareHeld contextRef="eol_PE402953--1210-K0005_STD_365_20110331_0_499577x629064_508454x644458" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_6E9E1CCE-0205-4A71-8226-A0DBF6B4B9F9_1001_0">0.02</mnov:BusinessAcquisitionCostOfAcquiredEntityCashPaidPerShareHeld>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_2_6">-16108434</us-gaap:OperatingIncomeLoss>
  <us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_1125627_71F7E133-71AA-4D94-86E6-D0471125BD9C_2_2">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_26">9715100</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_5">41869</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_3">1372748</us-gaap:ShareBasedCompensation>
  <us-gaap:IncreaseDecreaseOfRestrictedInvestments contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_14">17</us-gaap:IncreaseDecreaseOfRestrictedInvestments>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="pure" xsi:nil="true" id="id_1125627_71F7E133-71AA-4D94-86E6-D0471125BD9C_2_5" />
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_2_17">-1.20</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33010_1300105">76473</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
  <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_31">-8230</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_1125627_71F7E133-71AA-4D94-86E6-D0471125BD9C_2_6">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="-4" id="id_1125627_A6E08A17-D4AE-4E6C-AC14-BC7764ED5FCF_2_4">80000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_16">-13308652</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_24">-6085</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:IncomeTaxesPaid contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_43">12010</us-gaap:IncomeTaxesPaid>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33010_1300106">8230</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:OtherNonoperatingExpense contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_2_8">81292</us-gaap:OtherNonoperatingExpense>
  <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_15">2500000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_1125627_71F7E133-71AA-4D94-86E6-D0471125BD9C_2_1">0.055</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33010_1300114">1951951</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_21">6085</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_35">-13159080</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_13">250333</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_2_4">8323715</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_11">-164563</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_1125627_2E33877D-3B3C-4FD6-8A45-8470F0951B62_2_0">1431000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33010_1300103">76263</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:OtherNonoperatingIncome contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_2_10">62316</us-gaap:OtherNonoperatingIncome>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_2_21">-1143</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33010_1300118">-1143</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_2_3">7784719</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_34">155657</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:OperatingLeasesRentExpenseMinimumRentals contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_2AA75423-F9FE-4E73-B9CE-71D153C7A917_7_5">529114</us-gaap:OperatingLeasesRentExpenseMinimumRentals>
  <us-gaap:OperatingExpenses contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_2_5">16108434</us-gaap:OperatingExpenses>
  <us-gaap:RepaymentsOfDebt contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_32">15000000</us-gaap:RepaymentsOfDebt>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_1125627_71F7E133-71AA-4D94-86E6-D0471125BD9C_2_0">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_1125627_71F7E133-71AA-4D94-86E6-D0471125BD9C_2_3">-0.371</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:Depreciation contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_AE850F9C-3E30-4001-8E48-673B5A3C5AA2_2_6">41869</us-gaap:Depreciation>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="INF" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_2_11">-17722503</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:InterestPaid contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_44">1088926</us-gaap:InterestPaid>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_2_18">14813156</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="shares" decimals="INF" id="id_1125627_160FA594-AA0F-4D8E-8EAA-6C75ED1CC0AE_2_3">8291357</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_2_13">-17734076</us-gaap:NetIncomeLoss>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_2_12">11573</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_2_16">-17734076</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_2_22">-17735219</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33010_1300115">2.50</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33010_1300102">1372748</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_27">5355854</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_946EBB50-9ECD-45E2-9C56-59705EF272AE_2_0">97929</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
  <us-gaap:InterestExpense contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_2_9">1595093</us-gaap:InterestExpense>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5C58E7B2-FA58-4E94-9D33-98ACB9D7BDFC_2_0">1.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <mnov:IssuanceOfWarrants contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_39">2882258</mnov:IssuanceOfWarrants>
  <mnov:EffectiveIncomeTaxRateReconciliationPermanentDifferences contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="pure" decimals="3" id="id_1125627_71F7E133-71AA-4D94-86E6-D0471125BD9C_2_4">-0.050</mnov:EffectiveIncomeTaxRateReconciliationPermanentDifferences>
  <mnov:AmortizationOfPremiumDiscountOnInvestmentSecuritiesConvertibleNotesAndDebtDiscountAndIssuanceCosts contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_6">-752124</mnov:AmortizationOfPremiumDiscountOnInvestmentSecuritiesConvertibleNotesAndDebtDiscountAndIssuanceCosts>
  <mnov:IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_12">-656196</mnov:IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent>
  <mnov:IssuanceOfCommonStockNetOfIssuanceCosts contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33010_1300116">48049</mnov:IssuanceOfCommonStockNetOfIssuanceCosts>
  <mnov:ProceedsFromConversionOfConvertibleNotes contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_30">76473</mnov:ProceedsFromConversionOfConvertibleNotes>
  <mnov:RestrictedAssetsCashUnrestrictedUponConversionOfConvertibleNotes contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_2_41">76473</mnov:RestrictedAssetsCashUnrestrictedUponConversionOfConvertibleNotes>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x503003" unitRef="iso4217_USD" decimals="0" id="id_1125627_82FE3EB1-31B7-40DD-8321-BBA3C0560A52_4003_4">15450000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:AmortizationOfFinancingCosts contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x503003" unitRef="iso4217_USD" decimals="0" id="id_1125627_82FE3EB1-31B7-40DD-8321-BBA3C0560A52_4003_2">504207</us-gaap:AmortizationOfFinancingCosts>
  <us-gaap:WriteOffOfDeferredDebtIssuanceCost contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x503003" unitRef="iso4217_USD" decimals="0" id="id_1125627_82FE3EB1-31B7-40DD-8321-BBA3C0560A52_4003_6">-188698</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
  <us-gaap:InterestPaid contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x503003" unitRef="iso4217_USD" decimals="0" id="id_1125627_82FE3EB1-31B7-40DD-8321-BBA3C0560A52_4003_5">450000</us-gaap:InterestPaid>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x503003_503845x507708" unitRef="iso4217_USD" decimals="0" id="id_1125627_82FE3EB1-31B7-40DD-8321-BBA3C0560A52_4001_4">15000000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:AmortizationOfFinancingCosts contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x503003_503845x598913" unitRef="iso4217_USD" decimals="0" id="id_1125627_82FE3EB1-31B7-40DD-8321-BBA3C0560A52_4002_2">504207</us-gaap:AmortizationOfFinancingCosts>
  <us-gaap:WriteOffOfDeferredDebtIssuanceCost contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x503003_503845x598913" unitRef="iso4217_USD" decimals="0" id="id_1125627_82FE3EB1-31B7-40DD-8321-BBA3C0560A52_4002_6">-188698</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
  <us-gaap:InterestPaid contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x503003_503845x598913" unitRef="iso4217_USD" decimals="0" id="id_1125627_82FE3EB1-31B7-40DD-8321-BBA3C0560A52_4002_5">450000</us-gaap:InterestPaid>
  <us-gaap:WriteOffOfDeferredDebtIssuanceCost contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x534321" unitRef="iso4217_USD" decimals="0" id="id_1125627_374F0890-CE80-4BB6-92C0-7B2DA7BDBE0B_4001_3">103296</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
  <us-gaap:AdjustmentForAmortization contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x534321" unitRef="iso4217_USD" decimals="0" id="id_1125627_374F0890-CE80-4BB6-92C0-7B2DA7BDBE0B_4001_2">-21426</us-gaap:AdjustmentForAmortization>
  <us-gaap:WriteOffOfDeferredDebtIssuanceCost contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x678600" unitRef="iso4217_USD" decimals="0" id="id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_4003_3">579147</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
  <us-gaap:AdjustmentForAmortization contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x678600" unitRef="iso4217_USD" decimals="0" id="id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_4003_2">-120129</us-gaap:AdjustmentForAmortization>
  <us-gaap:WriteOffOfDeferredDebtIssuanceCost contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x678600_503845x532020" unitRef="iso4217_USD" decimals="0" id="id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_4002_3">86079</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
  <us-gaap:AdjustmentForAmortization contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x678600_503845x532020" unitRef="iso4217_USD" decimals="0" id="id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_4002_2">-17855</us-gaap:AdjustmentForAmortization>
  <us-gaap:WriteOffOfDeferredDebtIssuanceCost contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x678600_511283x507958" unitRef="iso4217_USD" decimals="0" id="id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_4001_3">493068</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
  <us-gaap:AdjustmentForAmortization contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x678600_511283x507958" unitRef="iso4217_USD" decimals="0" id="id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_4001_2">-102274</us-gaap:AdjustmentForAmortization>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_498752x505060" unitRef="iso4217_USD" decimals="-5" id="id_1125627_A6E08A17-D4AE-4E6C-AC14-BC7764ED5FCF_1002_1">1100000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_498752x506779" unitRef="iso4217_USD" decimals="-5" id="id_1125627_A6E08A17-D4AE-4E6C-AC14-BC7764ED5FCF_2002_2">300000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_500742x508125" unitRef="pure" decimals="4" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_1002_6">0.0027</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_500742x508125" unitRef="pure" decimals="2" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_1002_8">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_500742x508125" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_1002_9">P6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_500742x508125" unitRef="pure" decimals="4" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_1002_7">0.7797</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_500849x506554" unitRef="pure" decimals="4" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_2002_1">0.0070</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_500849x506554" unitRef="pure" decimals="2" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_2002_3">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_500849x506554" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_2002_4">P5Y4M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_500849x506554" unitRef="pure" decimals="4" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_2002_2">0.7879</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x500724" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33007_1000118">-1143</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33003_600104">11246</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33003_600103">32836</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x501348" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33003_700105">12</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33003_700114">800</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33003_700103">31</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33003_600114">800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x501348_507189x534959" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_34003_700108">2801</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x501348_507189x534959" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_34003_600107">2800666</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x502884" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33008_1100106">8230</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33009_1200117">-17734076</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x503547_513696x511225" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_35001_500111">2200</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x503547_513696x511225" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_35001_400111">220000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x508619" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33005_800105">76461</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33005_800114">1951151</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33005_800103">76232</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_33005_800102">1372748</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x508619_507189x534959" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_34005_800108">7684085</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x508619_513696x511225" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_35005_800111">5353654</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_507189x534959" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_34010_1300108">7686886</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <mnov:IssuanceOfUnitsInPublicOfferingNetOfIssuanceCosts contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_507189x534959" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_34010_1300110">715112</mnov:IssuanceOfUnitsInPublicOfferingNetOfIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_513696x501348" unitRef="shares" decimals="INF" id="id_1125627_A6E08A17-D4AE-4E6C-AC14-BC7764ED5FCF_3002_3">32836</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_513696x511225" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_35010_1300111">5355854</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_513696x511225" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_35010_1300113">144146</us-gaap:PaymentsOfStockIssuanceCosts>
  <mnov:PreferredStockIssuanceDollarAmountPerShare contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_513696x511225" unitRef="iso4217_USD_per_shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_35010_1300112">25</mnov:PreferredStockIssuanceDollarAmountPerShare>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_514791x503547" unitRef="shares" decimals="INF" id="id_1125627_160FA594-AA0F-4D8E-8EAA-6C75ED1CC0AE_1002_0">2200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_514791x507958" unitRef="shares" decimals="INF" id="id_1125627_160FA594-AA0F-4D8E-8EAA-6C75ED1CC0AE_2002_2">2998686</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE402953--1210-K0005_STD_365_20111231_0_514791x514283" unitRef="shares" decimals="INF" id="id_1125627_160FA594-AA0F-4D8E-8EAA-6C75ED1CC0AE_3002_1">3092671</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE402953--1210-K0005_STD_366_20001231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_2010_1300005">-201325</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20001231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_2010_1300001">50000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:EquityIssuancePerShareAmount contextRef="eol_PE402953--1210-K0005_STD_366_20001231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_2010_1300002">1.00</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20001231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_2003_700001">50</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20001231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_2003_600001">50000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE402953--1210-K0005_STD_366_20001231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_2009_1200005">-201325</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20001231_0_505872x503547_513696x498640" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_3001_500003">5000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20001231_0_505872x503547_513696x498640" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_3001_400003">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20001231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_2005_800001">49950</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20001231_0_505872x508619_513696x498640" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_3005_800003">4995000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20001231_0_513696x498640" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_3010_1300003">5000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <mnov:PreferredStockIssuanceDollarAmountPerShare contextRef="eol_PE402953--1210-K0005_STD_366_20001231_0_513696x498640" unitRef="iso4217_USD_per_shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_3010_1300004">10</mnov:PreferredStockIssuanceDollarAmountPerShare>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_13010_1300021">34069916</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_13010_1300026">-48272603</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_13010_1300025">78756</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
  <mnov:AmortizationOfDeferredEmployeeStockBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_13010_1300023">224579</mnov:AmortizationOfDeferredEmployeeStockBasedCompensation>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_13009_1200026">-48272603</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x503287" unitRef="iso4217_USD" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_13009_1200025">78756</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x503287_513696x501142" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_14009_1200024">-31264677</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x503547_513696x511225" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_15001_500018">1837</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x503547_513696x511225" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_15001_400018">183650</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <mnov:AmortizationOfDeferredEmployeeStockBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x508051" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_13006_900023">224579</mnov:AmortizationOfDeferredEmployeeStockBasedCompensation>
  <mnov:EmployeeStockBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x508051" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_13006_900022">-1419300</mnov:EmployeeStockBasedCompensation>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_13005_800021">34069916</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <mnov:EmployeeStockBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_13005_800022">1419300</mnov:EmployeeStockBasedCompensation>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x508619_513696x501142" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_14005_800024">31264677</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x508619_513696x511225" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_15005_800018">17154267</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0_513696x511225" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_15010_1300018">17156104</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0_513696x511225" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_15010_1300020">1208896</us-gaap:PaymentsOfStockIssuanceCosts>
  <mnov:PreferredStockIssuanceDollarAmountPerShare contextRef="eol_PE402953--1210-K0005_STD_366_20041231_0_513696x511225" unitRef="iso4217_USD_per_shares" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_15010_1300019">100</mnov:PreferredStockIssuanceDollarAmountPerShare>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_366_20081231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_26010_1300078">86726</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_366_20081231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_26010_1300082">101722</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_366_20081231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_26010_1300081">-21924829</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_366_20081231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_26010_1300077">3172712</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <mnov:AverageValueOfSharesIssuedUnderEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_366_20081231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_26010_1300079">2.33</mnov:AverageValueOfSharesIssuedUnderEmployeeStockPurchasePlan>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_366_20081231_0_505872x500724" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_26007_1000082">101722</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_366_20081231_0_505872x502884" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_26008_1100078">86726</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_366_20081231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_26009_1200081">-21924829</us-gaap:NetIncomeLoss>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_366_20081231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_26005_800077">3172712</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <dei:TradingSymbol contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_FB236EEF-BFE5-4EA6-9963-433DC44C83C8_1_400000">MNOV</dei:TradingSymbol>
  <dei:EntityRegistrantName contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_FB236EEF-BFE5-4EA6-9963-433DC44C83C8_1_400001">MEDICINOVA INC</dei:EntityRegistrantName>
  <dei:EntityCurrentReportingStatus contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_FB236EEF-BFE5-4EA6-9963-433DC44C83C8_1_400005">Yes</dei:EntityCurrentReportingStatus>
  <dei:AmendmentFlag contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_91F4FF99-29EB-41E1-9F48-73BE08C77236_1_1">false</dei:AmendmentFlag>
  <dei:EntityFilerCategory contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_FB236EEF-BFE5-4EA6-9963-433DC44C83C8_1_400007">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:DocumentFiscalPeriodFocus contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_91F4FF99-29EB-41E1-9F48-73BE08C77236_1_4">FY</dei:DocumentFiscalPeriodFocus>
  <dei:EntityVoluntaryFilers contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_FB236EEF-BFE5-4EA6-9963-433DC44C83C8_1_400006">No</dei:EntityVoluntaryFilers>
  <dei:DocumentFiscalYearFocus contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_91F4FF99-29EB-41E1-9F48-73BE08C77236_1_3">2012</dei:DocumentFiscalYearFocus>
  <dei:DocumentType contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_91F4FF99-29EB-41E1-9F48-73BE08C77236_1_0">10-K</dei:DocumentType>
  <dei:DocumentPeriodEndDate contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_91F4FF99-29EB-41E1-9F48-73BE08C77236_1_2">2012-12-31</dei:DocumentPeriodEndDate>
  <dei:EntityCentralIndexKey contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_FB236EEF-BFE5-4EA6-9963-433DC44C83C8_1_400002">0001226616</dei:EntityCentralIndexKey>
  <dei:EntityWellKnownSeasonedIssuer contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_FB236EEF-BFE5-4EA6-9963-433DC44C83C8_1_400004">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:CurrentFiscalYearEndDate contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_FB236EEF-BFE5-4EA6-9963-433DC44C83C8_1_400003">--12-31</dei:CurrentFiscalYearEndDate>
  <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_6C234D63-CCBA-4AA4-BD32-FE5056E77025_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Future minimum
payments as of December&amp;#xA0;31, 2012 are as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="80%" align="center"&gt;
&lt;tr&gt;
&lt;td width="88%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Years ending
December&amp;#xA0;31:&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2013&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;77,039&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total minimum
payments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;77,039&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_FA13E278-E398-472D-84FC-8A50DEFB81F9_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Basis of
Presentation&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Our primary
activities since incorporation have been recruiting personnel,
conducting research and development, performing business and
financial planning and raising capital. Accordingly, in connection
with preparation of the consolidated financial statements we
operate under one reporting segment and are considered to be in the
development stage, in accordance with the authoritative guidance
for development stage entities.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During the
first quarter of 2005, we completed our initial public offering, or
IPO, of 3,000,000 shares of common stock in Japan for proceeds of
$104.5 million, net of underwriting discounts and commissions and
offering costs. In December 2006, we were listed on the Nasdaq
Global Market. Accordingly, we are a public company in both the
U.S. and Japan, as our stock is traded on both the Nasdaq Global
Market and the Jasdaq Market (formerly the Hercules Market of the
Osaka Securities Exchange until its closure in 2010).&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Avigen
Transaction.&lt;/i&gt; On December&amp;#xA0;18, 2009, we acquired 100% of the
outstanding shares of Avigen, a biopharmaceutical company whose
potential product candidate, MN-166, is a therapeutic for Central
Nervous System, or CNS, disorders. Under the terms of the
transaction, Avigen shareholders, at their election, received an
amount per share either in cash, Convertible Notes or a combination
thereof, upon closing. Avigen shareholders holding approximately
17% of the Avigen common stock outstanding at the closing date
elected to receive cash in the amount of approximately $1.19 per
share. The remaining Avigen shareholders received the corresponding
value of Convertible Notes. Holders of the Convertible Notes could
convert their notes into our common stock at an initial conversion
price of $6.80 per share through May&amp;#xA0;31, 2011. At the maturity
of the Convertible Notes, the remaining holders would be paid the
same per share amount as the Avigen shareholders that elected to
receive cash at the closing, plus accrued interest. All Avigen
shareholders were also entitled to receive approximately $0.04 per
share, which was paid in two increments in 2010, and rights under
contingent payment rights issued. In March 2011 we paid $0.02 per
share to former Avigen shareholders related to the management
transition plan Contingent Payment Rights (CPR).&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Avigen
Management Transition Plan (MTP).&lt;/i&gt; On March&amp;#xA0;11, 2011, a
designated representative from Avigen notified us of the
termination of the Avigen MTP, with the final distribution to occur
on or about March&amp;#xA0;31, 2011. In connection with the termination
of the Avigen MTP and pursuant to the related contingent payment
rights agreement, the remaining funds were distributed to American
Stock Transfer&amp;#xA0;&amp;amp; Trust Company, LLC, or AST, and AST was
instructed to distribute the funds to the Avigen shareholders on a
pro rata basis (approximately $0.02 per share) based on the shares
of Avigen common stock held immediately prior to the effective time
of the Merger.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Joint
Venture&lt;/i&gt;&lt;i&gt;.&lt;/i&gt; We entered into an agreement to form a joint
venture company with Zhejiang Medicine Co.,&amp;#xA0;Ltd. and Beijing
Make-Friend Medicine Technology Co., Ltd. effective
September&amp;#xA0;27, 2011. The joint venture agreement provides for
the joint venture company, Zhejiang Sunmy Bio-Medical Co., Ltd.
(&amp;#x201C;Zhejiang Sunmy&amp;#x201D;),to develop and commercialize MN-221
in China. A sublicense agreement will be required under which
Zhejiang Sunmy will license MN-221 from us. In accordance with the
joint venture agreement, in March 2012 we paid $680,000 for a 30%
interest in Zhejiang Sunmy. The other parties to the joint venture
agreement provided funding for their combined 70% interest. We have
not entered into the sublicense of MN-221 with Zhejiang Sunmy as of
the date of this filing. Zhejiang Sunmy is a variable interest
entity for which we are not the primary beneficiary as we do not
have a majority of the board seats and we will not have power to
direct or significantly influence the actions of the entity. We
therefore account for the activities of Zhejiang Sunmy under the
equity method whereby we absorb any loss or income generated by
Zhejiang Sunmy according to our percentage ownership. At
December&amp;#xA0;31, 2012 we reflect a long-term asset on our
consolidated balance sheet which represents our investment in
Zhejiang Sunmy, net of our portion of any generated loss or
income.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_D667C493-347D-48F2-9225-4E30D8EC43B9_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;A
reconciliation of the federal statutory income tax rate to our
effective income tax rate is as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="76%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Year&amp;#xA0;Ended&amp;#xA0;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Federal statutory income
tax rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;State income taxes, net of
federal benefit&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.8&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Tax credits&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;
&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.6&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Change in valuation
allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(40.1&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(37.1&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Permanent
differences&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.7&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(5.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;
&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;
&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Provision for income
taxes&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_1_6">-10945356</us-gaap:OperatingIncomeLoss>
  <us-gaap:RevenueRecognitionDeferredRevenue contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_247397B1-8BA8-4BD6-A3B0-FA18DF2DDC10_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Deferred Revenue and
Revenue Recognition&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In October
2011, we entered into an agreement with Kissei Pharmaceutical Co.,
Ltd., or Kissei, to perform research and development services
relating to MN-221 in exchange for a non-refundable upfront payment
of $2.5&amp;#xA0;million. Under the terms of the agreement we are
responsible for all costs to be incurred in the performance of
these services. Certain of these research and development services
were completed in 2012 and the remaining services are expected to
be delivered and completed after 2013. We assessed the deliverables
in accordance with the authoritative guidance and concluded the
existence of one deliverable, research and development services. As
such, we are recognizing as revenue the $2.5 million payment as the
research and development services are performed. The amount
received from Kissei, net of the amount recorded as revenue, is
included on the balance sheet as deferred revenue and will be
recognized as revenue as we perform the remaining services. Revenue
recorded in 2012 was $0.8 million. No revenue was recorded in
2011.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:RevenueRecognitionDeferredRevenue>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_26">1486603</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38010_1300124">100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_E3E27C13-48DC-4F1B-9764-0555ACB7029E_1_0">P7Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:GainLossOnDispositionOfAssets contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_8">-823</us-gaap:GainLossOnDispositionOfAssets>
  <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_1125627_2F6BD9AD-AA6C-4417-B102-3F4FC8DBFF32_2_1">800000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_63BD3EB3-F7DE-4C76-B0B7-B11403C7C20E_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Equipment&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Property and
equipment, net, which consists of leasehold improvements, furniture
and equipment and software, is stated at cost. Leasehold
improvements, furniture and equipment, and software are depreciated
using the straight-line method over the estimated useful lives of
the related assets. The useful life for furniture, equipment (other
than computers) and software is five years, computers is three
years and leasehold improvements are amortized over the lesser of
the useful life or the term of the lease.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:PaymentsToAcquireInterestInJointVenture contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_22">680000</us-gaap:PaymentsToAcquireInterestInJointVenture>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_D7E4B23E-FEE4-4B5B-A036-4067E706EE62_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Cash and Cash
Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Cash and cash
equivalents consist of cash and other highly liquid investments
with original maturities of three months or less from the date of
purchase. Cash equivalents at December&amp;#xA0;31, 2012 consisted of
money market funds.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_5">69528</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_3">709650</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_1B7DF365-A773-4CE7-A051-E989B735835D_1_2">2.01</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="pure" xsi:nil="true" id="id_1125627_71F7E133-71AA-4D94-86E6-D0471125BD9C_1_5" />
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_406D4CB9-3B78-40EE-AADD-104FF9A3EC62_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Recent Accounting
Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In
May&amp;#xA0;2011, the Financial Accounting Standards Board, or FASB,
issued updated accounting guidance that clarifies existing fair
value measurements and disclosures, and eliminates differences
between GAAP and International Financial Reporting Standards to
make convergence guidance more understandable. This guidance is
effective for interim and annual periods beginning after
December&amp;#xA0;15, 2011. The adoption of this guidance did not have
a material impact on the Company&amp;#x2019;s consolidated financial
statements.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In September
2011, the FASB, issued guidance to simplify how entities test for
goodwill impairment. The updated guidance permits an assessment of
qualitative factors to determine whether it is more likely than not
that the fair value of a reporting unit in which goodwill resides
is less than its carrying value. For reporting units in which this
assessment concludes it is more likely than not that the fair value
is more than its carrying value, the updated guidance eliminates
the requirement to perform further goodwill impairment testing.
This new guidance is effective for fiscal years beginning after
December&amp;#xA0;15, 2011. The adoption of this guidance did not have
a material impact on the Company&amp;#x2019;s consolidated financial
statements.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Effective
January&amp;#xA0;1, 2012, the Company adopted guidance issued by the
FASB, concerning presentation and disclosure only for the
presentation of comprehensive (loss) income. The adoption of this
guidance did not have a material impact on the Company&amp;#x2019;s
consolidated financial position or results of operations, other
than its impact on the presentation of comprehensive (loss)
income.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In August 2012,
the FASB issued updated guidance to 2011 guidance that permits an
assessment of the qualitative factors to determine whether it is
more likely than not that the fair value of a reporting unit in
which goodwill resides is less than its carrying value. This
updated guidance is effective for annual and interim impairment
tests performed for fiscal years beginning after September&amp;#xA0;15,
2012 with early adoption permitted. The adoption of this standard
is not expected to have a material impact on our consolidated
financial statements.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_1B7DF365-A773-4CE7-A051-E989B735835D_1_4">4.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_397B021F-9A85-4667-866D-1F3A3F4D615B_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The significant
components of our deferred income taxes at December&amp;#xA0;31, 2012
and 2011 are as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="76%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;12/31/12&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;12/31/11&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred Tax
Assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net operating loss
carryforwards&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;83,783,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;79,215,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Capitalized
licenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,822,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,067,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research tax
credits&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,145,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,124,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Stock Options&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;570,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;395,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Other, net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;862,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;988,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total Deferred Tax
Assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;94,182,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;89,789,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred Tax
Liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In process
R&amp;amp;D&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,956,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,956,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total Deferred Tax
Liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,956,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,956,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net deferred tax
assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;92,226,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;87,833,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
Allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(94,182,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(89,789,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Net Deferred Tax
Liability&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,956,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,956,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_FF5C9C72-E0BE-499F-9318-1E737A44D47E_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;1. The Company, Basis of
Presentation and Summary of Significant Accounting
Policies&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: -6px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;The
Company&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="PADDING-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We were
incorporated in the state of Delaware in September 2000. We are a
development stage biopharmaceutical company focused on acquiring
and developing novel, small molecule therapeutics for the treatment
of serious diseases with unmet medical needs with a commercial
focus on the U.S. market. We are currently focusing our development
activities on MN-166, an ibudilast-based drug candidate for the
treatment of neurological disorders, and obtaining additional
funding to advance clinical trial development of MN-221, a novel,
highly selective &amp;#xDF;&lt;/font&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="1"&gt;&lt;sub style="POSITION: relative; VERTICAL-ALIGN: baseline; TOP: 0.4ex"&gt;2&lt;/sub&gt;&lt;/font&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;-adrenergic
receptor agonist being developed for the treatment of acute
exacerbations of asthma and chronic obstructive pulmonary disease,
or COPD.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As a
development stage company, we have consumed substantial amounts of
capital since our inception. We do not have material commitments
for capital expenditures. We do conduct clinical trials which are
administered by third-party CROs and there is a significant degree
of estimation involved in quantifying the expense associated with
clinical trial activity. We accrue costs for work performed by CROs
based on the achievement of contracted milestone activities and on
internal estimates of activities using patient enrollment and
contractual or estimated rates during the period. Our R&amp;amp;D
expense and cash payments in future periods could potentially be
impacted if we were not to receive complete and accurate
information from the CRO or other third parties on a timely basis
or correctly estimate the outcome of contract negotiations,
activity levels and enrollment rates.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We have had,
and will continue to have an ongoing need to raise additional cash
from outside sources to fund our operations. Our business will
continue to require us to incur substantial research and
development expenses and management plans to continue financing
operations with equity issuances, debt arrangements or a
combination thereof.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We incurred
losses of $11.0 million and $17.7 million for the years ended
December&amp;#xA0;31, 2012 and 2011 respectively. We have a history of
recurring losses from operations and have an accumulated deficit of
$296.2&amp;#xA0;million as of December&amp;#xA0;31, 2012. Additionally, we
have used net cash of $11.9 million and $13.3 million to fund our
operating activities for the years ended December&amp;#xA0;31, 2012 and
2011, respectively&lt;b&gt;.&lt;/b&gt; To date, these operating losses have
been funded primarily through the private placement of our equity
securities, the public sale of our common stock, long-term debt and
the exercise of founders&amp;#x2019; warrants.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As of
December&amp;#xA0;31, 2012, we had available cash and cash equivalents
of $4.0 million and working capital of $3.4 million. We presently
estimate that we have sufficient working capital to fund operations
through June&amp;#xA0;30, 2013. The Company will require additional
cash funding to continue to execute its strategic plan and fund
operations through December&amp;#xA0;31, 2013. These factors raise
substantial doubt about the Company&amp;#x2019;s ability to continue as
a going concern. The accompanying consolidated financial statements
have been prepared assuming the Company will continue as a going
concern. This basis of accounting contemplates the recovery of the
Company&amp;#x2019;s assets and the satisfaction of liabilities in the
normal course of business and does not include any adjustments to
reflect the possible future effects on the recoverability and
classification of assets or the amounts and classification of
liabilities that might be necessary should the Company be unable to
continue as a going concern.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Between
August&amp;#xA0;21, 2012 and the date of this report, the Company has
generated proceeds of $3.0 million under the Common Stock Purchase
Agreement with Aspire Capital Fund LLC (&amp;#x201C;Aspire&amp;#x201D;)
including proceeds of $1.5 million on the sale 800,000 shares of
its common stock subsequent to December&amp;#xA0;31, 2012 (see Note 7).
We have the right, subject to the terms of the Common Stock
Purchase Agreement, to cause Aspire to acquire up to 3,231,096
shares for total gross proceeds not to exceed $20 million
(including the 2,019,696 shares issued or sold to Aspire to date
for $3.0 million), subject to daily dollar limitations and subject
to the maximum dollar amount we can sell from time to time under
our registration statement on Form S-3. We expect to sell
additional shares under this agreement during 2013. We are also
pursuing other opportunities to raise capital through the sale of
our common stock or through other strategic initiatives. There can
be no assurances that there will be adequate financing available to
us on acceptable terms, or at all. If the Company is unable to
obtain additional financing, we may have to seek buyers for one or
more of our programs or cease operations.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Basis of
Presentation&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Our primary
activities since incorporation have been recruiting personnel,
conducting research and development, performing business and
financial planning and raising capital. Accordingly, in connection
with preparation of the consolidated financial statements we
operate under one reporting segment and are considered to be in the
development stage, in accordance with the authoritative guidance
for development stage entities.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;During the
first quarter of 2005, we completed our initial public offering, or
IPO, of 3,000,000 shares of common stock in Japan for proceeds of
$104.5 million, net of underwriting discounts and commissions and
offering costs. In December 2006, we were listed on the Nasdaq
Global Market. Accordingly, we are a public company in both the
U.S. and Japan, as our stock is traded on both the Nasdaq Global
Market and the Jasdaq Market (formerly the Hercules Market of the
Osaka Securities Exchange until its closure in 2010).&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Avigen
Transaction.&lt;/i&gt; On December&amp;#xA0;18, 2009, we acquired 100% of the
outstanding shares of Avigen, a biopharmaceutical company whose
potential product candidate, MN-166, is a therapeutic for Central
Nervous System, or CNS, disorders. Under the terms of the
transaction, Avigen shareholders, at their election, received an
amount per share either in cash, Convertible Notes or a combination
thereof, upon closing. Avigen shareholders holding approximately
17% of the Avigen common stock outstanding at the closing date
elected to receive cash in the amount of approximately $1.19 per
share. The remaining Avigen shareholders received the corresponding
value of Convertible Notes. Holders of the Convertible Notes could
convert their notes into our common stock at an initial conversion
price of $6.80 per share through May&amp;#xA0;31, 2011. At the maturity
of the Convertible Notes, the remaining holders would be paid the
same per share amount as the Avigen shareholders that elected to
receive cash at the closing, plus accrued interest. All Avigen
shareholders were also entitled to receive approximately $0.04 per
share, which was paid in two increments in 2010, and rights under
contingent payment rights issued. In March 2011 we paid $0.02 per
share to former Avigen shareholders related to the management
transition plan Contingent Payment Rights (CPR).&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Avigen
Management Transition Plan (MTP).&lt;/i&gt; On March&amp;#xA0;11, 2011, a
designated representative from Avigen notified us of the
termination of the Avigen MTP, with the final distribution to occur
on or about March&amp;#xA0;31, 2011. In connection with the termination
of the Avigen MTP and pursuant to the related contingent payment
rights agreement, the remaining funds were distributed to American
Stock Transfer&amp;#xA0;&amp;amp; Trust Company, LLC, or AST, and AST was
instructed to distribute the funds to the Avigen shareholders on a
pro rata basis (approximately $0.02 per share) based on the shares
of Avigen common stock held immediately prior to the effective time
of the Merger.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Joint
Venture&lt;/i&gt;&lt;i&gt;.&lt;/i&gt; We entered into an agreement to form a joint
venture company with Zhejiang Medicine Co.,&amp;#xA0;Ltd. and Beijing
Make-Friend Medicine Technology Co., Ltd. effective
September&amp;#xA0;27, 2011. The joint venture agreement provides for
the joint venture company, Zhejiang Sunmy Bio-Medical Co., Ltd.
(&amp;#x201C;Zhejiang Sunmy&amp;#x201D;),to develop and commercialize MN-221
in China. A sublicense agreement will be required under which
Zhejiang Sunmy will license MN-221 from us. In accordance with the
joint venture agreement, in March 2012 we paid $680,000 for a 30%
interest in Zhejiang Sunmy. The other parties to the joint venture
agreement provided funding for their combined 70% interest. We have
not entered into the sublicense of MN-221 with Zhejiang Sunmy as of
the date of this filing. Zhejiang Sunmy is a variable interest
entity for which we are not the primary beneficiary as we do not
have a majority of the board seats and we will not have power to
direct or significantly influence the actions of the entity. We
therefore account for the activities of Zhejiang Sunmy under the
equity method whereby we absorb any loss or income generated by
Zhejiang Sunmy according to our percentage ownership. At
December&amp;#xA0;31, 2012 we reflect a long-term asset on our
consolidated balance sheet which represents our investment in
Zhejiang Sunmy, net of our portion of any generated loss or
income.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Principles of
Consolidation&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
consolidated financial statements include the accounts of
MediciNova, Inc. and its wholly-owned subsidiaries. MediciNova,
Inc. and its subsidiaries are collectively referred to herein as
&amp;#x201C;we,&amp;#x201D; &amp;#x201C;our&amp;#x201D; or &amp;#x201C;us.&amp;#x201D;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
December&amp;#xA0;13, 2006, MediciNova (Europe) Limited, a wholly-owned
subsidiary of MediciNova, Inc., was incorporated under the laws of
England and Wales and established for the purpose of facilitating
the clinical development of the Company&amp;#x2019;s product candidates
for the European marketplace. MediciNova (Europe) Limited&amp;#x2019;s
functional currency is the U.S. dollar, the reporting currency of
its parent.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
January&amp;#xA0;4, 2007, MediciNova Japan, Inc., a wholly-owned
subsidiary of MediciNova, Inc., was incorporated under the laws of
Japan and established to strengthen business development and
investor and public relations activities in Japan and other Asian
countries. MediciNova Japan, Inc.&amp;#x2019;s functional currency is
the Japanese yen.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
August&amp;#xA0;17, 2009, Absolute Merger, Inc., a wholly-owned
subsidiary of MediciNova, Inc. was incorporated under the General
Corporation Law of the State of Delaware for the purpose of
facilitating the merger with Avigen.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;All
intercompany transactions and investments in our subsidiaries have
been eliminated in consolidation.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Use of
Estimates&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The preparation
of consolidated financial statements in conformity with U.S.
generally accepted accounting principles requires management to
make estimates and assumptions that affect the amounts reported in
the financial statements and accompanying notes. Actual results may
differ from these estimates under different assumptions or
conditions.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Cash and Cash
Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Cash and cash
equivalents consist of cash and other highly liquid investments
with original maturities of three months or less from the date of
purchase. Cash equivalents at December&amp;#xA0;31, 2012 consisted of
money market funds.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Deferred Revenue and
Revenue Recognition&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In October
2011, we entered into an agreement with Kissei Pharmaceutical Co.,
Ltd., or Kissei, to perform research and development services
relating to MN-221 in exchange for a non-refundable upfront payment
of $2.5&amp;#xA0;million. Under the terms of the agreement we are
responsible for all costs to be incurred in the performance of
these services. Certain of these research and development services
were completed in 2012 and the remaining services are expected to
be delivered and completed after 2013. We assessed the deliverables
in accordance with the authoritative guidance and concluded the
existence of one deliverable, research and development services. As
such, we are recognizing as revenue the $2.5 million payment as the
research and development services are performed. The amount
received from Kissei, net of the amount recorded as revenue, is
included on the balance sheet as deferred revenue and will be
recognized as revenue as we perform the remaining services. Revenue
recorded in 2012 was $0.8 million. No revenue was recorded in
2011.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;At-The-Market
Issuance Sales Agreement&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On May&amp;#xA0;5,
2011, we entered into an at-the-market, or ATM, issuance sales
agreement, or sales agreement, with McNicoll, Lewis&amp;#xA0;&amp;amp; Vlak
LLC, or MLV, pursuant to which we could issue and sell shares of
our common stock having an aggregate offering price of up to $15.0
million from time to time through MLV as our sales agent. The
issuance and sale of these shares by us under the sales agreement,
if any, would be subject to the effectiveness of our shelf
registration statement on Form&amp;#xA0;S-3 (File No.&amp;#xA0;333-163116),
initially filed with the Securities and Exchange Commission on
November&amp;#xA0;13, 2009.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Effective
October&amp;#xA0;23, 2011, we terminated the ATM between us and MLV. No
shares of common stock were issued under the ATM.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Concentrations and
Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We maintain
cash balances at various financial institutions and such balances
commonly exceed the $250,000 amount insured by the Federal Deposit
Insurance Corporation. We also maintain money market funds at
various financial institutions which are not federally insured
although are invested primarily in U.S. government securities. We
have not experienced any losses in such accounts and management
believes that we do not have significant credit risk with respect
to such cash and cash equivalents.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Goodwill and
Purchased Intangibles&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Goodwill is
recorded when the consideration paid for an acquisition exceeds the
fair value of the identified net tangible and intangible assets of
acquired businesses. The allocation of purchase price for
acquisitions require extensive use of accounting estimates and
judgments to allocate the purchase price to the identifiable
tangible and intangible assets acquired and liabilities assumed
based on their respective fair values. Additionally, we must
determine whether an acquired entity is considered to be a business
or a set of net assets as a portion of the purchase price can only
be allocated to goodwill in a business combination. Goodwill and
intangible assets deemed to have indefinite lives are not
amortized, but are subject to annual impairment tests. The amounts
and useful lives assigned to intangible assets that have finite
useful lives require the use of estimates and the exercise of
judgment. These judgments can significantly affect our net
operating results. We recorded goodwill and IPR&amp;amp;Dof
$9.6&amp;#xA0;million and $4.8 million, respectively, as of
December&amp;#xA0;31, 2012 and 2011.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Our annual test
date for goodwill and purchased indefinite life intangibles
impairment is December&amp;#xA0;31 or more frequently if we believe
indicators of impairment are present. We periodically re-evaluate
the original assumptions and rationale utilized in the
establishment of the carrying value and estimated lives of our
long-lived assets. The criteria used for these evaluations include
management&amp;#x2019;s estimate of the asset&amp;#x2019;s continuing ability
to generate income from operations and positive cash flows in
future periods as well as the strategic significance of any
intangible assets in our business objectives. If assets are
considered to be impaired, the impairment recognized is the amount
by which the carrying value of the assets exceeds the fair value of
the assets.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Fair
Value&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Financial
instruments, including cash equivalents, accounts payable and
accrued liabilities, are carried at cost, which we believe
approximates fair value given their short-term nature. We are
required to measure certain assets and liabilities at fair value,
either upon initial measurement or for subsequent accounting or
reporting. We use fair value in the initial measurement of net
assets acquired in a business combination and when accounting for
and reporting on investment securities and certain financial
instruments or assets. We estimate fair value using an exit price
approach, which requires, among other things, that we determine the
price that would be received to sell an asset or paid to transfer a
liability in an orderly market of market participants, considering
the highest and best use of assets and, for liabilities, assuming
the risk of non-performance will be the same before and after the
transfer. Many, but not all, of our financial instruments are
carried at fair value.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The judgments
made in determining an estimate of fair value can materially impact
our results of operations.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Equipment&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Property and
equipment, net, which consists of leasehold improvements, furniture
and equipment and software, is stated at cost. Leasehold
improvements, furniture and equipment, and software are depreciated
using the straight-line method over the estimated useful lives of
the related assets. The useful life for furniture, equipment (other
than computers) and software is five years, computers is three
years and leasehold improvements are amortized over the lesser of
the useful life or the term of the lease.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Research and
Development&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research and
development expenses consist of costs incurred to further our
research and development activities and include salaries and
related employee benefits, costs associated with clinical trials,
costs associated with non-clinical activities such as regulatory
activities, research-related overhead expenses, and fees paid to
external service providers who conduct certain research and
development activities on our behalf. We use external service
providers and vendors to conduct clinical trials, to manufacture
product candidates to be used in clinical trials and to provide
various other products and services related to our product
development programs. Research and development expenses also
include fees for licensed technology for which technological
feasibility has not been established and there are no alternative
uses. Research and development costs are expensed as incurred or
accrued based on certain contractual provisions such as those for
estimates of work performed, milestones achieved and patient
enrollment. As actual costs become known, accruals are adjusted if
necessary. To date, our accrual estimates have not differed
significantly from the actual costs incurred.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Income
Taxes&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In accordance
with the authoritative guidance for income taxes under ASC 740, a
deferred tax asset or liability is determined based on the
difference between the financial statement and the tax basis of
assets and liabilities as measured by the enacted tax rates, which
will be in effect when these differences reverse. We provide a
valuation allowance against net deferred tax assets unless, based
upon the available evidence, it is more likely than not that the
deferred tax assets will be realized.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
recognizes the impact of a tax position in the financial statements
only if that position is more likely than not of being sustained
upon examination by taxing authorities, based on the technical
merits of the position. Our practice is to recognize interest
and/or penalties related to income tax matters in income tax
expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We are subject
to taxation in the U.S., California and foreign jurisdictions, of
which currently no years are under examination. Our tax years for
2000 and forward are subject to examination by the U.S. and state
tax authorities due to the carry-forward of unutilized net
operating losses and research and development credits. During each
of the two years in the period ended December&amp;#xA0;31, 2012, income
tax expense relates to intercompany service income earned by our
Japanese subsidiary, MediciNova Japan, Inc.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Stock-Based
Compensation&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We award
options to purchase our common stock to our employees and directors
and under our Amended and Restated 2004 Stock Incentive Plan (the
&amp;#x201C;2004 Plan&amp;#x201D;), the successor to our 2000 General Stock
Incentive Plan (the &amp;#x201C;2000 Plan&amp;#x201D;). The cost of these
employee awards is measured according to the grant date fair value
of the stock award and is recognized on a straight-line basis over
the period during which an employee is required to provide service
in exchange for the award, which is usually the vesting period. We
occasionally issue employee performance based stock options, the
vesting of which is subsequently based on a determination made by
the Company&amp;#x2019;s board of directors as to the achievement of
certain corporate objectives. The grant date of such awards is the
date on which our board of directors makes its determination. For
periods preceding the grant date, the cost of these awards is
measured according to their fair value at each reporting date.
Stock options awarded to non-employees were recorded at their fair
value as determined in accordance with the authoritative guidance
for equity under ASC 505.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Under the
MediciNova, Inc. 2007 Employee Stock Purchase Plan, or ESPP,
300,000 shares of our common stock have been reserved for issuance.
In addition, the shares reserved will automatically increase by a
number equal to the lesser of: (i)&amp;#xA0;15,000 shares, (ii)&amp;#xA0;1%
of the outstanding shares of our common stock on the last day of
the immediately preceding fiscal year or (iii)&amp;#xA0;such lesser
amount as determined by the Board. The ESPP permits full-time
employees to purchase our common stock through payroll deductions
(which cannot exceed 15% of each employee&amp;#x2019;s compensation) at
the lower of 85% of fair market value at the beginning of the
offering period or the end of each six-month offering
period.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The exercise
price of stock options granted during the years ended
December&amp;#xA0;31, 2012 and 2011 were equal to market value on the
date of grant. During the years ended December&amp;#xA0;31, 2012 and
2011, options to purchase 750,000 and 1,431,000 shares of common
stock, respectively, were granted. For the year ended
December&amp;#xA0;31, 2012, 35,414 shares were issued under the ESPP,
leaving 249,578 shares available for future issuance. Stock-based
compensation expense for such stock options and employee stock
purchase place are reflected in total operating expense for each
respective year. The estimated fair value of each stock option
award was determined on the date of grant using the Black-Scholes
option valuation model with the following weighted-average
assumptions for stock option grants:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="80%" align="center"&gt;
&lt;tr&gt;
&lt;td width="83%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Year&amp;#xA0;Ended&lt;br /&gt;
December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Stock
Options&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Risk-free interest
rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.67&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.70&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected volatility of
common stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;83.26&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;78.79&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.00&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.00&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected option term (in
years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.31&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.36&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Employee Stock Purchase
Plan&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Risk-free interest
rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.30&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.27&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected volatility of
common stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;79.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;77.97&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.00&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.00&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected option term (in
years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The risk-free
interest rate assumption is based upon observed interest rates
appropriate for the expected term of our employee stock options.
The expected volatility is based on the historical volatility of
our stock since listing on the Nasdaq Global Market in December
2006. We have not paid nor do we anticipate paying dividends on our
common stock in the foreseeable future. The expected term of
employee stock options is based on the simplified method as
provided by the authoritative guidance on stock compensation, as we
concluded that our historical stock option exercise experience does
not provide a reasonable basis for us to estimate the expected
term.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
weighted-average fair value of each stock option granted during the
years ended December&amp;#xA0;31, 2012 and 2011, estimated as of the
grant date using the Black-Scholes option valuation model, was
$1.33 per option and $1.25 per option, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;For the years
ended December&amp;#xA0;31, 2012 and 2011, stock-based compensation
expense related to stock options and the employee stock purchase
plan was $0.7 million and $1.4 million, respectively, and was
recorded as a component of general and administrative expense ($0.4
million and $1.1 million, respectively) and research and
development expense ($0.3 million and $0.3 million, respectively).
During the years ended December&amp;#xA0;31, 2012 and 2011, there were
60,000 and 32,836 stock options exercised, respectively, from which
proceeds of $0.1&amp;#xA0;million and $0.08 million, respectively, were
received.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As of
December&amp;#xA0;31, 2012, there was $1.0 million of unamortized
compensation cost related to unvested stock option awards which is
expected to be recognized over a remaining weighted-average vesting
period of 1.2 years, on a straight-line basis.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Net Loss Per
Share&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss per
common share is presented as basic and diluted net loss per common
share. Basic net loss per common share is calculated by dividing
the net loss attributable to common stockholders by the weighted
average number of common shares outstanding for the period, without
consideration for common stock equivalents. Diluted net loss per
common share is calculated by dividing the net loss attributable to
common stockholders by the weighted average number of common shares
outstanding for the period using the treasury-stock method. For
purposes of this calculation, convertible preferred stock, stock
options and warrants are considered to be common stock equivalents
and are only included in the calculation of diluted net loss per
common share when their effect is dilutive.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Potentially
dilutive outstanding securities excluded from diluted net loss per
common share because of their anti-dilutive effect:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="80%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Convertible preferred
stock, as converted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,200,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,200,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Stock options&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,328,981&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,092,671&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,128,686&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,998,686&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,657,667&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,291,357&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Recent Accounting
Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In
May&amp;#xA0;2011, the Financial Accounting Standards Board, or FASB,
issued updated accounting guidance that clarifies existing fair
value measurements and disclosures, and eliminates differences
between GAAP and International Financial Reporting Standards to
make convergence guidance more understandable. This guidance is
effective for interim and annual periods beginning after
December&amp;#xA0;15, 2011. The adoption of this guidance did not have
a material impact on the Company&amp;#x2019;s consolidated financial
statements.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In September
2011, the FASB, issued guidance to simplify how entities test for
goodwill impairment. The updated guidance permits an assessment of
qualitative factors to determine whether it is more likely than not
that the fair value of a reporting unit in which goodwill resides
is less than its carrying value. For reporting units in which this
assessment concludes it is more likely than not that the fair value
is more than its carrying value, the updated guidance eliminates
the requirement to perform further goodwill impairment testing.
This new guidance is effective for fiscal years beginning after
December&amp;#xA0;15, 2011. The adoption of this guidance did not have
a material impact on the Company&amp;#x2019;s consolidated financial
statements.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Effective
January&amp;#xA0;1, 2012, the Company adopted guidance issued by the
FASB, concerning presentation and disclosure only for the
presentation of comprehensive (loss) income. The adoption of this
guidance did not have a material impact on the Company&amp;#x2019;s
consolidated financial position or results of operations, other
than its impact on the presentation of comprehensive (loss)
income.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In August 2012,
the FASB issued updated guidance to 2011 guidance that permits an
assessment of the qualitative factors to determine whether it is
more likely than not that the fair value of a reporting unit in
which goodwill resides is less than its carrying value. This
updated guidance is effective for annual and interim impairment
tests performed for fiscal years beginning after September&amp;#xA0;15,
2012 with early adoption permitted. The adoption of this standard
is not expected to have a material impact on our consolidated
financial statements.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_1_17">-0.66</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_A04B885A-CC41-4E32-89D8-6A45B0C3A08F_1_400003">60000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_A7662871-96C2-4FAF-81F7-94BC2DDC1212_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;4. Balance Sheet
Details&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Property and
Equipment&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Property and
equipment, net, consist of the following:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="80%" align="center"&gt;
&lt;tr&gt;
&lt;td width="73%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Leasehold
improvements&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;170,386&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;172,648&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Furniture and
equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;351,992&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;561,332&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Software&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;228,397&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;221,380&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;750,775&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;955,360&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less accumulated
depreciation and amortization&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(672,301&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(925,935&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;78,474&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;29,425&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Depreciation
expense&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;33,507&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;41,869&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Accrued
Expenses&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accrued
expenses consist of the following:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="80%" align="center"&gt;
&lt;tr&gt;
&lt;td width="72%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research and development
costs&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;152,046&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;615,792&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Professional services
fees&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;68,102&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;100,823&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Joint venture capital
contribution payable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;650,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;94,504&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;149,200&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;314,652&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,515,815&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
  <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_31">-58619</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_FD25FFE3-8B0A-427F-AB0F-ADA616906720_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;5. Related Party
Transactions&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We entered into
a stock purchase agreement dated September&amp;#xA0;26, 2011 with
Kissei, under which on October&amp;#xA0;13, 2011 Kissei purchased for
$7.5 million&amp;#xA0;an aggregate of 800,000 shares of our common
stock and&amp;#xA0;220,000 shares of our Series&amp;#xA0;B Convertible
Preferred Stock. On the same day, we entered into a letter
agreement with Kissei pursuant to which we agreed to renegotiate in
good faith the existing levels of the milestone payment amounts and
royalty rates under our license agreement for MN-221 and agreed
upon a new price for clinical supplies of API. On October&amp;#xA0;13,
2011 we entered into a services agreement with Kissei to perform
two separate studies relating to MN-221 in exchange for $2.5
million paid to us in October, 2011. We are responsible for all
costs to be incurred in the performance of these studies. The
amount received from Kissei, net of the amount recorded as revenue
through December&amp;#xA0;31, 2012, is included on the balance sheet at
December&amp;#xA0;31, 2012 as deferred revenue and will be recognized
as revenue in future periods as we perform the remaining
services.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_1125627_71F7E133-71AA-4D94-86E6-D0471125BD9C_1_6">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-4" id="id_1125627_A6E08A17-D4AE-4E6C-AC14-BC7764ED5FCF_1_4">100000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_1EF4B440-2B90-49C7-A71F-0D61B80A9E17_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;9. Employee Savings
Plan&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We have an
employee savings plan available to substantially all employees.
Under the plan, an employee may elect salary reductions which are
contributed to the plan. The plan provides for discretionary
contributions by us, which totaled $96,415, $97,929, and $1,196,091
for the years ended December&amp;#xA0;31, 2012, 2011 and the period
from September&amp;#xA0;26, 2000 (inception) to December&amp;#xA0;31, 2012,
respectively.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_16">-11864438</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_24">-763378</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:IncomeTaxesPaid contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_43">10951</us-gaap:IncomeTaxesPaid>
  <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_6AFB8883-F46F-412C-9BEA-EB61F966F51C_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Property and
equipment, net, consist of the following:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="80%" align="center"&gt;
&lt;tr&gt;
&lt;td width="73%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Leasehold
improvements&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;170,386&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;172,648&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Furniture and
equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;351,992&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;561,332&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Software&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;228,397&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;221,380&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;750,775&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;955,360&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Less accumulated
depreciation and amortization&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(672,301&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(925,935&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;78,474&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;29,425&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Depreciation
expense&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;33,507&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;41,869&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38010_1300122">58619</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:OtherNonoperatingExpense contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_1_8">29605</us-gaap:OtherNonoperatingExpense>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_1B7DF365-A773-4CE7-A051-E989B735835D_1_3">2.30</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_1125627_71F7E133-71AA-4D94-86E6-D0471125BD9C_1_1">0.058</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38010_1300123">1348873</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_21">83378</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_35">-11082594</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_13">-370964</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_1_4">6734844</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_1125627_F308FC51-9146-461C-B295-EEE3F6177891_2_1">1900000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_11">-266927</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_2E33877D-3B3C-4FD6-8A45-8470F0951B62_1_0">750000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:SubsequentEventsTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_E9896425-B5D4-4451-8C21-37B2FA89EF8E_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;11. Subsequent
Events&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;Lease
Amendment&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
February&amp;#xA0;27, 2013, we entered into a sublease agreement
effective March&amp;#xA0;1, 2013 (the &amp;#x201C;Sublease&amp;#x201D;) with
Denali Advisors, LLC, the sublessor, to which Irvine Company, the
master landlord, has provided its consent. The Sublease is for the
Company&amp;#x2019;s new headquarters located at 4275 Executive Square,
Suite 650, La Jolla, California, 92037. The Sublease has a term of
4 years and 9 months and provides that the Company will pay Irvine
Company a monthly base rent of $10,699 for the premises during the
first year.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_2F7ACEEA-E2F2-46CD-9D48-3B9AE82E6610_1_1">P1Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_671802F0-60B8-457F-9374-C16CF63C163B_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;A summary of
our stock option activity and related information as of
December&amp;#xA0;31, 2012 is as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="67%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Number&amp;#xA0;of&lt;br /&gt;
Option&amp;#xA0;Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Weighted&amp;#xA0;Average&lt;br /&gt;
Exercise&amp;#xA0;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at
January&amp;#xA0;1, 2012&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,092,671&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.52&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;750,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.01&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(60,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.30&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(453,690&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.57&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at
December&amp;#xA0;31, 2012&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,328,981&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.92&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercisable at
December&amp;#xA0;31, 2012&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,089,963&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.32&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38010_1300121">137730</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:OtherNonoperatingIncome contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_1_10">24791</us-gaap:OtherNonoperatingIncome>
  <us-gaap:RepurchaseAndResaleAgreementsPolicy contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_C6F8C412-0B93-4765-8B9B-A2AA62B4AF2A_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;At-The-Market
Issuance Sales Agreement&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On May&amp;#xA0;5,
2011, we entered into an at-the-market, or ATM, issuance sales
agreement, or sales agreement, with McNicoll, Lewis&amp;#xA0;&amp;amp; Vlak
LLC, or MLV, pursuant to which we could issue and sell shares of
our common stock having an aggregate offering price of up to $15.0
million from time to time through MLV as our sales agent. The
issuance and sale of these shares by us under the sales agreement,
if any, would be subject to the effectiveness of our shelf
registration statement on Form&amp;#xA0;S-3 (File No.&amp;#xA0;333-163116),
initially filed with the Securities and Exchange Commission on
November&amp;#xA0;13, 2009.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Effective
October&amp;#xA0;23, 2011, we terminated the ATM between us and MLV. No
shares of common stock were issued under the ATM.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:RepurchaseAndResaleAgreementsPolicy>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_1_21">-11112</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_2C87C4B2-C120-4E7F-8B87-DBB846BB4DEF_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The estimated
fair value of each stock option award was determined on the date of
grant using the Black-Scholes option valuation model with the
following weighted-average assumptions for stock option
grants:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="80%" align="center"&gt;
&lt;tr&gt;
&lt;td width="83%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Year&amp;#xA0;Ended&lt;br /&gt;
December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Stock
Options&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Risk-free interest
rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.67&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.70&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected volatility of
common stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;83.26&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;78.79&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.00&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.00&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected option term (in
years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.31&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.36&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Employee Stock Purchase
Plan&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Risk-free interest
rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.30&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.27&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected volatility of
common stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;79.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;77.97&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.00&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.00&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected option term (in
years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38010_1300127">-11112</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_1_3">5013092</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_2E33877D-3B3C-4FD6-8A45-8470F0951B62_1_1">35414</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_34">1545222</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_43A1F333-56E5-4465-ADFE-56B0ADF9C668_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
table presents our financial instruments measured at fair value on
a recurring basis classified by the fair value measurements and
disclosures valuation hierarchy (in thousands):&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="66%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;As of December&amp;#xA0;31,
2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Fair&amp;#xA0;Value&amp;#xA0;Measurements&amp;#xA0;Using&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Level&amp;#xA0;1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Level&amp;#xA0;2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Level&amp;#xA0;3&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,720&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,720&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="66%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;As of December&amp;#xA0;31,
2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Fair&amp;#xA0;Value&amp;#xA0;Measurements&amp;#xA0;Using&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Level&amp;#xA0;1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Level&amp;#xA0;2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Level&amp;#xA0;3&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,690&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,690&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_C203A522-08C2-4AD5-A7D7-54D421692A16_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Income
Taxes&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In accordance
with the authoritative guidance for income taxes under ASC 740, a
deferred tax asset or liability is determined based on the
difference between the financial statement and the tax basis of
assets and liabilities as measured by the enacted tax rates, which
will be in effect when these differences reverse. We provide a
valuation allowance against net deferred tax assets unless, based
upon the available evidence, it is more likely than not that the
deferred tax assets will be realized.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The Company
recognizes the impact of a tax position in the financial statements
only if that position is more likely than not of being sustained
upon examination by taxing authorities, based on the technical
merits of the position. Our practice is to recognize interest
and/or penalties related to income tax matters in income tax
expense.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We are subject
to taxation in the U.S., California and foreign jurisdictions, of
which currently no years are under examination. Our tax years for
2000 and forward are subject to examination by the U.S. and state
tax authorities due to the carry-forward of unutilized net
operating losses and research and development credits. During each
of the two years in the period ended December&amp;#xA0;31, 2012, income
tax expense relates to intercompany service income earned by our
Japanese subsidiary, MediciNova Japan, Inc.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_FCF19F5A-F3A8-427D-A663-4D6C8A9322D3_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Potentially
dilutive outstanding securities excluded from diluted net loss per
common share because of their anti-dilutive effect:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="80%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Convertible preferred
stock, as converted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,200,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,200,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Stock options&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,328,981&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,092,671&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,128,686&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,998,686&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,657,667&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,291,357&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_C31F6B42-B567-4B2E-9791-A701033C07A9_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2. Fair Value
Measurements&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As defined in
the authoritative guidance for fair value measurements and
disclosures under ASC 820, fair value is based on the price that
would be received to sell an asset or would be paid to transfer a
liability in an orderly transaction between market participants at
the measurement date. To increase the comparability and consistency
of fair value measurements, ASC 820 prescribes a fair value
hierarchy that prioritizes observable and unobservable inputs used
to measure fair value into three broad levels which are described
below:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="90%" align="center"&gt;
&lt;tr&gt;
&lt;td width="7%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td width="89%"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Level&amp;#xA0;1:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Inputs are quoted prices (unadjusted) in active markets
for identical assets or liabilities at the measurement
date.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="16"&gt;&lt;/td&gt;
&lt;td height="16" colspan="2"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Level&amp;#xA0;2:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Inputs are quoted prices for similar items in active
markets or inputs are quoted prices for identical or similar items
in markets that are not active.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="16"&gt;&lt;/td&gt;
&lt;td height="16" colspan="2"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Level&amp;#xA0;3:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Inputs are unobservable due to little or no market data
availability and inputs are usually developed by management or a
third-party which reflect those inputs that a market participant
would use. The fair value hierarchy gives the lowest priority to
Level 3 inputs.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
table presents our financial instruments measured at fair value on
a recurring basis classified by the fair value measurements and
disclosures valuation hierarchy (in thousands):&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="66%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;As of December&amp;#xA0;31,
2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Fair&amp;#xA0;Value&amp;#xA0;Measurements&amp;#xA0;Using&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Level&amp;#xA0;1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Level&amp;#xA0;2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Level&amp;#xA0;3&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,720&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,720&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="66%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;As of December&amp;#xA0;31,
2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Fair&amp;#xA0;Value&amp;#xA0;Measurements&amp;#xA0;Using&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Level&amp;#xA0;1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Level&amp;#xA0;2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Level&amp;#xA0;3&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Cash equivalents&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,690&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,690&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;At
December&amp;#xA0;31, 2012, cash equivalents (instruments with
maturities of three months or less at the date of purchase) were
primarily invested in money market accounts, the fair value of
which is based on Level 1 criteria in which their carrying amount
is a reasonable estimate of their fair value based on daily quoted
market prices. At December&amp;#xA0;31, 2012 and 2011 we did not hold
financial instruments measured at fair value on a non-recurring
basis.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
  <us-gaap:OperatingLeasesRentExpenseMinimumRentals contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_2AA75423-F9FE-4E73-B9CE-71D153C7A917_6_5">286762</us-gaap:OperatingLeasesRentExpenseMinimumRentals>
  <us-gaap:OperatingExpenses contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_1_5">11747936</us-gaap:OperatingExpenses>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_62E7B72F-FCA7-4715-8324-EEDB82AB3FB2_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;8. Income
Taxes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The significant
components of our deferred income taxes at December&amp;#xA0;31, 2012
and 2011 are as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="76%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;12/31/12&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;12/31/11&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred Tax
Assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net operating loss
carryforwards&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;83,783,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;79,215,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Capitalized
licenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,822,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,067,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research tax
credits&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,145,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,124,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Stock Options&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;570,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;395,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Other, net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;862,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;988,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total Deferred Tax
Assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;94,182,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;89,789,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred Tax
Liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In process
R&amp;amp;D&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,956,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,956,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total Deferred Tax
Liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,956,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,956,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net deferred tax
assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;92,226,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;87,833,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Valuation
Allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(94,182,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(89,789,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Net Deferred Tax
Liability&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,956,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1,956,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We have
established a valuation allowance against our deferred tax assets
due to the uncertainty that such assets will be realized. We
periodically evaluate the recoverability of the deferred tax
assets. At such time as it is determined that it is more likely
than not that deferred tax assets will be realizable, the valuation
allowance will be reduced.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;At
December&amp;#xA0;31, 2012, we had federal and California net operating
loss, or NOL, carryforwards of approximately $205.7 million and
$205.1 million, respectively. The federal net operating loss
carryforwards begin to expire in 2020, and the California net
operating loss carryforwards begin to expire in 2013. At
December&amp;#xA0;31, 2012, we also had federal and California research
tax credit carryforwards of approximately $6.2 million and $1.4
million, respectively. The federal research tax credit
carryforwards begin to expire in 2024, and the California research
tax credit carryforward does not expire and can be carried forward
indefinitely until utilized.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The above NOL
carryforward and the research tax credit carryforwards are subject
to an annual limitation under Section&amp;#xA0;382 and 383 of the
Internal Revenue Code of 1986, and similar state provisions due to
ownership change limitations that have occurred which will limit
the amount of NOL and tax credit carryforwards that can be utilized
to offset future taxable income and tax, respectively. In general,
an ownership change, as defined by Section&amp;#xA0;382 and 383,
results from transactions increasing ownership of certain
stockholders or public groups in the stock of the corporation by
more than 50 percentage points over a three-year period. Multiple
ownership changes have occurred in previous years which created
annual limitations on our ability to utilize NOL and tax credit
carryovers. Such limitations will result in approximately $7.3
million and $1 million of tax benefits related to federal and state
NOL and tax credit carryforwards, respectively, that will expire
unused. Accordingly, the related NOL and research credit
carryforwards are not reflected in the deferred tax assets or the
corresponding valuation allowance above. Due to the existence of
the valuation allowance, limitations created by future ownership
changes, if any, related to our operations in the U.S. will not
impact our effective tax rate.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;A
reconciliation of the federal statutory income tax rate to our
effective income tax rate is as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="76%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Year&amp;#xA0;Ended&amp;#xA0;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Federal statutory income
tax rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;State income taxes, net of
federal benefit&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.8&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Tax credits&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;
&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1.6&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Change in valuation
allowance&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(40.1&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(37.1&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Permanent
differences&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.7&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(5.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;
&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;
&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Provision for income
taxes&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We file income
tax returns in the United States, California and foreign
jurisdictions. Due to our losses incurred, we are essentially
subject to income tax examination by tax authorities from our
inception to date. Our policy is to recognize interest expense and
penalties related to income tax matters as tax expense. At
December&amp;#xA0;31, 2012, there are no unrecognized tax benefits, and
we do not have any significant accruals for interest related to
unrecognized tax benefits or tax penalties.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:NumberOfReportableSegments contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="Segment" decimals="INF" id="id_1125627_B542EB64-FCDF-43E9-BA63-72383A0D2F26_1_0">1</us-gaap:NumberOfReportableSegments>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_1125627_71F7E133-71AA-4D94-86E6-D0471125BD9C_1_0">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:ConsolidationPolicyTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_53E3B6A6-EF80-4FB5-BD46-2526258E435A_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Principles of
Consolidation&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
consolidated financial statements include the accounts of
MediciNova, Inc. and its wholly-owned subsidiaries. MediciNova,
Inc. and its subsidiaries are collectively referred to herein as
&amp;#x201C;we,&amp;#x201D; &amp;#x201C;our&amp;#x201D; or &amp;#x201C;us.&amp;#x201D;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
December&amp;#xA0;13, 2006, MediciNova (Europe) Limited, a wholly-owned
subsidiary of MediciNova, Inc., was incorporated under the laws of
England and Wales and established for the purpose of facilitating
the clinical development of the Company&amp;#x2019;s product candidates
for the European marketplace. MediciNova (Europe) Limited&amp;#x2019;s
functional currency is the U.S. dollar, the reporting currency of
its parent.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
January&amp;#xA0;4, 2007, MediciNova Japan, Inc., a wholly-owned
subsidiary of MediciNova, Inc., was incorporated under the laws of
Japan and established to strengthen business development and
investor and public relations activities in Japan and other Asian
countries. MediciNova Japan, Inc.&amp;#x2019;s functional currency is
the Japanese yen.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
August&amp;#xA0;17, 2009, Absolute Merger, Inc., a wholly-owned
subsidiary of MediciNova, Inc. was incorporated under the General
Corporation Law of the State of Delaware for the purpose of
facilitating the merger with Avigen.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;All
intercompany transactions and investments in our subsidiaries have
been eliminated in consolidation.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_C9214338-F6AB-4EC8-9F30-4FBDD4602784_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;10. Quarterly Financial
Data (Unaudited)&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
financial information reflects all normal recurring adjustments,
which are, in the opinion of management, necessary for a fair
statement of the results of the interim periods. Summarized
quarterly data for fiscal 2012 and 2011 are as follows (in
thousands, except per share data):&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="64%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Year Ended
December&amp;#xA0;31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;1st&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2nd&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;3rd&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;4th&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Selected quarterly
financial data:&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Revenues&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;191&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;494&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;84&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;34&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total operating
expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,064&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,781&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,446&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,455&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(3,867&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,281&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,379&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,434&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss applicable to
common stockholders&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(3,867&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,281&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,379&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,434&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Basic and diluted net loss
per common share(1)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.24&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.14&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.14&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.14&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="64%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Year Ended
December&amp;#xA0;31, 2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;1st&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2nd&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;3rd&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;4th&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Selected quarterly
financial data:&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total operating
expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,976&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,722&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,907&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,503&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(5,656&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4,681&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(3,894&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(3,503&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss applicable to
common stockholders&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(5,656&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4,681&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(3,894&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(3,503&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Basic and diluted net loss
per common share(1)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.45&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.31&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.25&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.22&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="BORDER-BOTTOM: #000000 0.5pt solid; LINE-HEIGHT: 8px; MARGIN-TOP: 0px; WIDTH: 10%; MARGIN-BOTTOM: 2px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr&gt;
&lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1)&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Loss per share is computed
independently for each of the quarters presented. The sum of the
quarterly net loss per share will not necessarily equal the total
for the year.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
  <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_6E2A1945-5EA8-4246-8B78-A61B222B26F3_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Accrued
expenses consist of the following:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="80%" align="center"&gt;
&lt;tr&gt;
&lt;td width="72%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research and development
costs&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;152,046&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;615,792&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Professional services
fees&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;68,102&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;100,823&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Joint venture capital
contribution payable&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;650,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Other&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;94,504&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;149,200&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;314,652&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;1,515,815&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_A04B885A-CC41-4E32-89D8-6A45B0C3A08F_1_400004">453690</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
  <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_A2729807-0A5F-4E56-BBAA-784B87E661B5_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Research and
Development&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Research and
development expenses consist of costs incurred to further our
research and development activities and include salaries and
related employee benefits, costs associated with clinical trials,
costs associated with non-clinical activities such as regulatory
activities, research-related overhead expenses, and fees paid to
external service providers who conduct certain research and
development activities on our behalf. We use external service
providers and vendors to conduct clinical trials, to manufacture
product candidates to be used in clinical trials and to provide
various other products and services related to our product
development programs. Research and development expenses also
include fees for licensed technology for which technological
feasibility has not been established and there are no alternative
uses. Research and development costs are expensed as incurred or
accrued based on certain contractual provisions such as those for
estimates of work performed, milestones achieved and patient
enrollment. As actual costs become known, accruals are adjusted if
necessary. To date, our accrual estimates have not differed
significantly from the actual costs incurred.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_E3E27C13-48DC-4F1B-9764-0555ACB7029E_1_1">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:Revenues contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_1_0">802580</us-gaap:Revenues>
  <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_1125627_71F7E133-71AA-4D94-86E6-D0471125BD9C_1_3">-0.401</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:Depreciation contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_AE850F9C-3E30-4001-8E48-673B5A3C5AA2_1_6">33507</us-gaap:Depreciation>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="INF" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_1_11">-10950170</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_FBE722F3-E95A-4700-9E5C-2BCEEE3DD329_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The table below
summarizes the long-term debt activity:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="34%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="22" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Year Ended
December&amp;#xA0;31, 2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Carrying&lt;br /&gt;
Value&lt;br /&gt;
12/31/2010&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Amortization&lt;br /&gt;
(Interest&lt;br /&gt;
Expense)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Amortization&lt;br /&gt;
(Other&lt;br /&gt;
Expense)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Payments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Write-Off&lt;br /&gt;
Debt&lt;br /&gt;
Related&lt;br /&gt;
Costs&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Carrying&lt;br /&gt;
Value&lt;br /&gt;
12/31/2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Other Assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Debt issuance costs paid to
third parties&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;124,722&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(21,426&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(103,296&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="8"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Liability:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Loan&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(15,000,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;15,000,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred interest
charge&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(134,491&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(504,207&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;450,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;188,698&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(15,134,491&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(504,207&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;15,450,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;188,698&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="8"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Contra
Liability:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Relative fair value of
warrants issued to lender(1)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;595,342&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(102,274&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(493,068&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Debt issuance costs paid to
lender&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;103,934&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(17,855&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(86,079&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;699,276&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(120,129&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(579,147&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="BORDER-BOTTOM: #000000 0.5pt solid; LINE-HEIGHT: 8px; MARGIN-TOP: 0px; WIDTH: 10%; MARGIN-BOTTOM: 2px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr&gt;
&lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1)&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The relative fair value of
the warrants issued to the lender was calculated using a
Black-Scholes valuation model. The risk-free interest rate
assumption was 2.86 percent based upon observed risk-free interest
rates appropriate for the expected term of the warrants. The
expected volatility assumption was 76 percent consistent with the
volatility of our common stock based on the historical volatility
of our stock since listing on the Nasdaq Global Market in December
2006. We have not paid and do not anticipate paying dividends on
our common stock since our inception, and therefore, the dividend
yield assumption was zero. The expected term assumption was seven
years, which is the contractual life of the warrants. The fair
value of the warrants using the Black-Scholes valuation model was
calculated to be $4.34 per share.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_3DD48F7B-9D42-4393-8E3E-7DC0C4132869_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Stock-Based
Compensation&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We award
options to purchase our common stock to our employees and directors
and under our Amended and Restated 2004 Stock Incentive Plan (the
&amp;#x201C;2004 Plan&amp;#x201D;), the successor to our 2000 General Stock
Incentive Plan (the &amp;#x201C;2000 Plan&amp;#x201D;). The cost of these
employee awards is measured according to the grant date fair value
of the stock award and is recognized on a straight-line basis over
the period during which an employee is required to provide service
in exchange for the award, which is usually the vesting period. We
occasionally issue employee performance based stock options, the
vesting of which is subsequently based on a determination made by
the Company&amp;#x2019;s board of directors as to the achievement of
certain corporate objectives. The grant date of such awards is the
date on which our board of directors makes its determination. For
periods preceding the grant date, the cost of these awards is
measured according to their fair value at each reporting date.
Stock options awarded to non-employees were recorded at their fair
value as determined in accordance with the authoritative guidance
for equity under ASC 505.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Under the
MediciNova, Inc. 2007 Employee Stock Purchase Plan, or ESPP,
300,000 shares of our common stock have been reserved for issuance.
In addition, the shares reserved will automatically increase by a
number equal to the lesser of: (i)&amp;#xA0;15,000 shares, (ii)&amp;#xA0;1%
of the outstanding shares of our common stock on the last day of
the immediately preceding fiscal year or (iii)&amp;#xA0;such lesser
amount as determined by the Board. The ESPP permits full-time
employees to purchase our common stock through payroll deductions
(which cannot exceed 15% of each employee&amp;#x2019;s compensation) at
the lower of 85% of fair market value at the beginning of the
offering period or the end of each six-month offering
period.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The exercise
price of stock options granted during the years ended
December&amp;#xA0;31, 2012 and 2011 were equal to market value on the
date of grant. During the years ended December&amp;#xA0;31, 2012 and
2011, options to purchase 750,000 and 1,431,000 shares of common
stock, respectively, were granted. For the year ended
December&amp;#xA0;31, 2012, 35,414 shares were issued under the ESPP,
leaving 249,578 shares available for future issuance. Stock-based
compensation expense for such stock options and employee stock
purchase place are reflected in total operating expense for each
respective year. The estimated fair value of each stock option
award was determined on the date of grant using the Black-Scholes
option valuation model with the following weighted-average
assumptions for stock option grants:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="80%" align="center"&gt;
&lt;tr&gt;
&lt;td width="83%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Year&amp;#xA0;Ended&lt;br /&gt;
December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Stock
Options&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Risk-free interest
rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.67&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.70&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected volatility of
common stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;83.26&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;78.79&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.00&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.00&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected option term (in
years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.31&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.36&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Employee Stock Purchase
Plan&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Risk-free interest
rate&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.30&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.27&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected volatility of
common stock&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;79.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;77.97&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.00&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.00&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;%&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Expected option term (in
years)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The risk-free
interest rate assumption is based upon observed interest rates
appropriate for the expected term of our employee stock options.
The expected volatility is based on the historical volatility of
our stock since listing on the Nasdaq Global Market in December
2006. We have not paid nor do we anticipate paying dividends on our
common stock in the foreseeable future. The expected term of
employee stock options is based on the simplified method as
provided by the authoritative guidance on stock compensation, as we
concluded that our historical stock option exercise experience does
not provide a reasonable basis for us to estimate the expected
term.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The
weighted-average fair value of each stock option granted during the
years ended December&amp;#xA0;31, 2012 and 2011, estimated as of the
grant date using the Black-Scholes option valuation model, was
$1.33 per option and $1.25 per option, respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;For the years
ended December&amp;#xA0;31, 2012 and 2011, stock-based compensation
expense related to stock options and the employee stock purchase
plan was $0.7 million and $1.4 million, respectively, and was
recorded as a component of general and administrative expense ($0.4
million and $1.1 million, respectively) and research and
development expense ($0.3 million and $0.3 million, respectively).
During the years ended December&amp;#xA0;31, 2012 and 2011, there were
60,000 and 32,836 stock options exercised, respectively, from which
proceeds of $0.1&amp;#xA0;million and $0.08 million, respectively, were
received.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;As of
December&amp;#xA0;31, 2012, there was $1.0 million of unamortized
compensation cost related to unvested stock option awards which is
expected to be recognized over a remaining weighted-average vesting
period of 1.2 years, on a straight-line basis.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_716B161B-4CF7-4C3F-95FC-0B62040FE7AD_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;6. Commitments and
Contingencies&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Facility
Lease&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On July&amp;#xA0;6,
2011, we entered into a fifth amendment (the &amp;#x201C;Fifth Lease
Amendment&amp;#x201D;) of our lease agreement (the &amp;#x201C;Lease&amp;#x201D;),
with 4350 La Jolla Village LLC (the &amp;#x201C;Landlord&amp;#x201D;). The
Fifth Lease Amendment amended and extended the Lease term from
August&amp;#xA0;31, 2011 to May&amp;#xA0;31, 2012. The Fifth Lease
Amendment provided that we pay the Landlord a monthly base rent of
$12,468 for the premises during the nine-month extension period. On
March&amp;#xA0;19, 2012, we entered into a sixth amendment of the Lease
(the &amp;#x201C;Sixth Lease Amendment&amp;#x201D;), which extended the lease
term through February&amp;#xA0;28, 2013, and provided that we pay the
Landlord a monthly base rent of $12,672 for the premises during the
term of the Sixth Lease Amendment. See Notes to Consolidated
Financial Statements-Note 11. Subsequent Events, for information
regarding a change in our headquarters and a new sublease
agreement. In June 2005, we leased office space in Tokyo, Japan
under a non-cancelable operating lease that expires in May 2013 and
provides for six month extensions thereafter. Rent expense for the
years ended December&amp;#xA0;31, 2012 and 2011 was $286,762 and
$529,114, respectively, and rent expense, net of sub-lease income
for the period from September&amp;#xA0;26, 2000 (inception) to
December&amp;#xA0;31, 2012 was $5.0 million.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Future minimum
payments as of December&amp;#xA0;31, 2012 are as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="80%" align="center"&gt;
&lt;tr&gt;
&lt;td width="88%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Years ending
December&amp;#xA0;31:&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2013&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;77,039&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total minimum
payments&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;77,039&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;License
Agreements&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Since our
inception, we have entered into eight license agreements with
pharmaceutical companies which cover our current product
candidates. In general, we seek to obtain exclusive licenses to the
patent rights and know-how for all indications under the agreements
within our licensed territories and to procure patent protection
for our anticipated products, or obtain such protection from the
relevant patents owned by our licensors. Under our license
agreements we generally are required to make an upfront payment and
additional payments upon the achievement of specific development
and/or regulatory approval milestones. We are also generally
obligated to pay royalties under the agreements until the later of
the expiration of the applicable patent or the applicable last date
of market exclusivity after the first commercial sale, on a
country-by-country basis.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The amounts
expended under these agreements and charged to research and
development expense from September&amp;#xA0;26, 2000 (inception) to
December&amp;#xA0;31, 2012 was $9,850,000. No such amounts have been
expended during the years ended December&amp;#xA0;31, 2012 or 2011. As
of December&amp;#xA0;31, 2012, future potential milestone payments
totaled $94.1 million, and there are no minimum royalties required
under any of the license agreements. We are unable at this time to
estimate with certainty the timing on when these milestone payments
will occur as these payments are dependent upon the progress of our
product development programs.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Legal
Proceedings&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
March&amp;#xA0;3, 2011, we received a letter, in which certain
allegations were made, from a former employee who had been
terminated in January 2011 pursuant to our planned
reduction-in-force. On July&amp;#xA0;8, 2011, the former employee filed
a lawsuit in the Superior Court of the State of California, County
of San Diego, asserting certain claims related to the
Company&amp;#x2019;s work environment and the employee&amp;#x2019;s
termination, and on December&amp;#xA0;12, 2011 the court granted our
motion to compel arbitration. On August&amp;#xA0;1, 2012 the arbitrator
stayed all proceedings to allow the plaintiff time to obtain new
counsel. The plaintiff has since obtained new counsel and the
arbitrator has continued the stay to allow our legal counsel and
the plaintiff&amp;#x2019;s new counsel to work out some final details
regarding documents and property previously held by the
plaintiff&amp;#x2019;s former counsel. Based on our current assessment,
we do not expect its outcome to have a material adverse effect on
our business, financial condition and results of
operations.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_1_18">16522929</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_160FA594-AA0F-4D8E-8EAA-6C75ED1CC0AE_1_3">8657667</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_1_13">-10961314</us-gaap:NetIncomeLoss>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_1_12">11144</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_1_16">-10961314</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="shares" decimals="INF" id="id_1125627_F308FC51-9146-461C-B295-EEE3F6177891_2_2">276655</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_1_22">-10972426</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:UseOfEstimates contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_14073ACC-50AC-47BC-AE05-4B292149104E_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Use of
Estimates&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The preparation
of consolidated financial statements in conformity with U.S.
generally accepted accounting principles requires management to
make estimates and assumptions that affect the amounts reported in
the financial statements and accompanying notes. Actual results may
differ from these estimates under different assumptions or
conditions.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_DBC02BC0-4DA6-44B2-AAA1-7DE09DAF3472_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Net Loss Per
Share&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss per
common share is presented as basic and diluted net loss per common
share. Basic net loss per common share is calculated by dividing
the net loss attributable to common stockholders by the weighted
average number of common shares outstanding for the period, without
consideration for common stock equivalents. Diluted net loss per
common share is calculated by dividing the net loss attributable to
common stockholders by the weighted average number of common shares
outstanding for the period using the treasury-stock method. For
purposes of this calculation, convertible preferred stock, stock
options and warrants are considered to be common stock equivalents
and are only included in the calculation of diluted net loss per
common share when their effect is dilutive.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Potentially
dilutive outstanding securities excluded from diluted net loss per
common share because of their anti-dilutive effect:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="80%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Convertible preferred
stock, as converted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,200,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,200,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Stock options&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,328,981&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,092,671&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,128,686&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,998,686&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,657,667&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;8,291,357&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38010_1300120">709650</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_806AF98E-F0FB-4644-925B-B5F6732A7C43_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Fair
Value&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Financial
instruments, including cash equivalents, accounts payable and
accrued liabilities, are carried at cost, which we believe
approximates fair value given their short-term nature. We are
required to measure certain assets and liabilities at fair value,
either upon initial measurement or for subsequent accounting or
reporting. We use fair value in the initial measurement of net
assets acquired in a business combination and when accounting for
and reporting on investment securities and certain financial
instruments or assets. We estimate fair value using an exit price
approach, which requires, among other things, that we determine the
price that would be received to sell an asset or paid to transfer a
liability in an orderly market of market participants, considering
the highest and best use of assets and, for liabilities, assuming
the risk of non-performance will be the same before and after the
transfer. Many, but not all, of our financial instruments are
carried at fair value.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The judgments
made in determining an estimate of fair value can materially impact
our results of operations.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:LongTermDebtTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_07EC4BAE-FF6F-4368-BB39-902C2230DA74_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;3. Long-term
Debt&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In
May&amp;#xA0;2010, we entered into a loan and security agreement, or
the Loan Agreement, with Oxford Finance Corporation, or Oxford,
under which we borrowed $15.0 million at a stated interest rate of
12.87&amp;#xA0;percent. Our obligations under the Loan Agreement were
secured by a first priority security interest in substantially all
of our assets, other than our intellectual property, and we also
agreed not to pledge or otherwise encumber our intellectual
property assets. Our obligations under the Loan Agreement were
guaranteed on a senior secured basis by Avigen. The Loan Agreement
also contained certain restrictive covenants.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Pursuant to the
Loan Agreement, we issued to Oxford a warrant to purchase up to
198,020 shares of our common stock, par value $0.001 per share. The
warrant is exercisable, immediately, in whole or in part, has a per
share exercise price of $6.06 and may be exercised on a cashless
basis. The warrant will terminate on the earlier of May&amp;#xA0;10,
2017 or the closing date of a merger or consolidation transaction
in which we are not the surviving entity. In addition, the warrant
and debt instrument were immediately separable and issued
separately. We accounted for the warrant as a component of
stockholders&amp;#x2019; equity as the agreement required settlement in
shares and under no provision of the agreement are we required to
settle the warrant in cash.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We accounted
for the interest on the debt using the effective interest method
wherein we treated the debt issuance costs paid directly to Oxford
and the relative fair value of the warrants issued to Oxford as a
discount on the debt, and we treated the debt issuance costs paid
to third parties (primarily legal fees) as an other asset in our
consolidated balance sheet. The amortization of the debt discount
was recorded as interest expense and the amortization of the debt
issuance costs paid to third parties was recorded as other expense
in our consolidated statement of operations and comprehensive
loss.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
March&amp;#xA0;31, 2011, we entered into an agreement with Oxford under
which we made an early repayment of the loan in-full and wherein
Oxford waived the prepayment penalty of approximately
$437,000.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The table below
summarizes the long-term debt activity:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="34%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="22" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Year Ended
December&amp;#xA0;31, 2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Carrying&lt;br /&gt;
Value&lt;br /&gt;
12/31/2010&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Amortization&lt;br /&gt;
(Interest&lt;br /&gt;
Expense)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Amortization&lt;br /&gt;
(Other&lt;br /&gt;
Expense)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Payments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Write-Off&lt;br /&gt;
Debt&lt;br /&gt;
Related&lt;br /&gt;
Costs&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Carrying&lt;br /&gt;
Value&lt;br /&gt;
12/31/2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Other Assets:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Debt issuance costs paid to
third parties&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;124,722&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(21,426&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(103,296&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="8"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Liability:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Loan&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(15,000,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;15,000,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Deferred interest
charge&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(134,491&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(504,207&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;450,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;188,698&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(15,134,491&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(504,207&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;15,450,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;188,698&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td height="8"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;td height="8" colspan="4"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Contra
Liability:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Relative fair value of
warrants issued to lender(1)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;595,342&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(102,274&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(493,068&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Debt issuance costs paid to
lender&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;103,934&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(17,855&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(86,079&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;699,276&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(120,129&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(579,147&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="BORDER-BOTTOM: #000000 0.5pt solid; LINE-HEIGHT: 8px; MARGIN-TOP: 0px; WIDTH: 10%; MARGIN-BOTTOM: 2px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr&gt;
&lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1)&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The relative fair value of
the warrants issued to the lender was calculated using a
Black-Scholes valuation model. The risk-free interest rate
assumption was 2.86 percent based upon observed risk-free interest
rates appropriate for the expected term of the warrants. The
expected volatility assumption was 76 percent consistent with the
volatility of our common stock based on the historical volatility
of our stock since listing on the Nasdaq Global Market in December
2006. We have not paid and do not anticipate paying dividends on
our common stock since our inception, and therefore, the dividend
yield assumption was zero. The expected term assumption was seven
years, which is the contractual life of the warrants. The fair
value of the warrants using the Black-Scholes valuation model was
calculated to be $4.34 per share.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
  <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_69316CDC-387C-4A0B-886D-9B756BF94426_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Goodwill and
Purchased Intangibles&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Goodwill is
recorded when the consideration paid for an acquisition exceeds the
fair value of the identified net tangible and intangible assets of
acquired businesses. The allocation of purchase price for
acquisitions require extensive use of accounting estimates and
judgments to allocate the purchase price to the identifiable
tangible and intangible assets acquired and liabilities assumed
based on their respective fair values. Additionally, we must
determine whether an acquired entity is considered to be a business
or a set of net assets as a portion of the purchase price can only
be allocated to goodwill in a business combination. Goodwill and
intangible assets deemed to have indefinite lives are not
amortized, but are subject to annual impairment tests. The amounts
and useful lives assigned to intangible assets that have finite
useful lives require the use of estimates and the exercise of
judgment. These judgments can significantly affect our net
operating results. We recorded goodwill and IPR&amp;amp;Dof
$9.6&amp;#xA0;million and $4.8 million, respectively, as of
December&amp;#xA0;31, 2012 and 2011.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Our annual test
date for goodwill and purchased indefinite life intangibles
impairment is December&amp;#xA0;31 or more frequently if we believe
indicators of impairment are present. We periodically re-evaluate
the original assumptions and rationale utilized in the
establishment of the carrying value and estimated lives of our
long-lived assets. The criteria used for these evaluations include
management&amp;#x2019;s estimate of the asset&amp;#x2019;s continuing ability
to generate income from operations and positive cash flows in
future periods as well as the strategic significance of any
intangible assets in our business objectives. If assets are
considered to be impaired, the impairment recognized is the amount
by which the carrying value of the assets exceeds the fair value of
the assets.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
  <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_946EBB50-9ECD-45E2-9C56-59705EF272AE_1_0">96415</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_5C58E7B2-FA58-4E94-9D33-98ACB9D7BDFC_1_0">1.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <mnov:EmployeeStockPurchasePlanNumberOfSharesAvailableForIssuance contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="shares" decimals="0" id="id_1125627_2E33877D-3B3C-4FD6-8A45-8470F0951B62_1_2">249578</mnov:EmployeeStockPurchasePlanNumberOfSharesAvailableForIssuance>
  <mnov:EffectiveIncomeTaxRateReconciliationPermanentDifferences contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="pure" decimals="3" id="id_1125627_71F7E133-71AA-4D94-86E6-D0471125BD9C_1_4">-0.007</mnov:EffectiveIncomeTaxRateReconciliationPermanentDifferences>
  <mnov:CumulativeStockOwnershipChangePeriod contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_C74877CB-0CEF-436D-910F-31BB6156EF02_2_1">P3Y</mnov:CumulativeStockOwnershipChangePeriod>
  <mnov:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_DC165FB6-BAFB-48F2-9579-3282A2BFE12A_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
table summarizes common stock reserved for future issuance at
December&amp;#xA0;31, 2012:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="90%" align="center"&gt;
&lt;tr&gt;
&lt;td width="87%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Common Stock under the
employee stock purchase program&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;249,578&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Common stock reserved for
issuance upon exercise of warrant&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,128,686&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Common stock options
outstanding (under the 2000 Plan and 2004 Plan)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,328,981&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Common stock options
authorized for future grant (under the 2004 Plan)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;466,752&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,173,997&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</mnov:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock>
  <mnov:AmortizationOfDeferredRevenue contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_4">-802580</mnov:AmortizationOfDeferredRevenue>
  <mnov:IncreaseInOwnershipPercentage contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="pure" decimals="2" id="id_1125627_C74877CB-0CEF-436D-910F-31BB6156EF02_2_0">0.50</mnov:IncreaseInOwnershipPercentage>
  <mnov:QuarterFinancialInformationTableTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_0D8016CF-3D50-4616-8727-750BB7337579_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Summarized
quarterly data for fiscal 2012 and 2011 are as follows (in
thousands, except per share data):&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="64%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Year Ended
December&amp;#xA0;31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;1st&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2nd&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;3rd&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;4th&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Selected quarterly
financial data:&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Revenues&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;191&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;494&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;84&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;34&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total operating
expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,064&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,781&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,446&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,455&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(3,867&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,281&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,379&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,434&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss applicable to
common stockholders&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(3,867&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,281&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,379&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(2,434&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Basic and diluted net loss
per common share(1)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.24&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.14&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.14&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.14&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="64%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Year Ended
December&amp;#xA0;31, 2011&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;1st&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;2nd&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;3rd&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;4th&lt;br /&gt;
Quarter&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Selected quarterly
financial data:&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Total operating
expenses&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4,976&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,722&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,907&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,503&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(5,656&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4,681&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(3,894&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(3,503&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Net loss applicable to
common stockholders&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(5,656&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(4,681&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(3,894&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(3,503&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Basic and diluted net loss
per common share(1)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.45&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.31&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.25&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(0.22&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="BORDER-BOTTOM: #000000 0.5pt solid; LINE-HEIGHT: 8px; MARGIN-TOP: 0px; WIDTH: 10%; MARGIN-BOTTOM: 2px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr&gt;
&lt;td valign="top" width="4%" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(1)&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Loss per share is computed
independently for each of the quarters presented. The sum of the
quarterly net loss per share will not necessarily equal the total
for the year.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</mnov:QuarterFinancialInformationTableTextBlock>
  <mnov:ConcentrationsAndUncertaintiesPolicyTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_18C7F9BB-B7EE-403E-88CA-3CB32DD247F4_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Concentrations and
Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We maintain
cash balances at various financial institutions and such balances
commonly exceed the $250,000 amount insured by the Federal Deposit
Insurance Corporation. We also maintain money market funds at
various financial institutions which are not federally insured
although are invested primarily in U.S. government securities. We
have not experienced any losses in such accounts and management
believes that we do not have significant credit risk with respect
to such cash and cash equivalents.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;</mnov:ConcentrationsAndUncertaintiesPolicyTextBlock>
  <mnov:IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_1_12">-776508</mnov:IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent>
  <mnov:StockholdersEquityAndStockBasedCompensationTextBlock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0" id="id_1125627_935B33C5-20CD-4949-8182-7011ACEE7AE1_1_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;7. Stockholders&amp;#x2019;
Equity&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Initial Public
Offering in Japan&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
February&amp;#xA0;8, 2005, we completed an IPO of 3,000,000 shares of
common stock in Japan and received aggregate proceeds of
$104,486,895, net of underwriting discounts and commissions and
offering expenses. In addition, on March&amp;#xA0;8, 2005, we closed
the sale of an additional 157,300 shares of our common stock
pursuant to the partial exercise by our underwriters of an
over-allotment option which resulted in aggregate proceeds to us of
$5,557,773, net of underwriting discounts and commissions. In
connection with our IPO, redeemable convertible and convertible
preferred stock outstanding as of February&amp;#xA0;8, 2005 was
automatically converted into 6,678,285 shares of common
stock.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Public Offering in
the U.S.&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
February&amp;#xA0;1, 2007, we completed a public offering of 1,000,000
shares of common stock in the U.S. at a purchase price of $12.00
per share and received aggregate net proceeds of approximately
$10,639,600, net of underwriting discounts and commissions and
offering expenses.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Redeemable
Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
September&amp;#xA0;2, 2004, we sold 27,667,856 shares of Series C
redeemable convertible preferred stock at a purchase price of $1.62
per share for total net proceeds of $43,404,320, net of issuance
costs. The Series C preferred stock was sold at a price per share
below our IPO price. Accordingly, pursuant to the authoritative
guidance for debt under ASC 470, we recorded a deemed dividend on
the Series C preferred stock of $31,264,677, which is equal to the
number of shares of Series C preferred stock sold multiplied by the
difference between the estimated fair value of the underlying
common stock and the Series C preferred stock conversion price per
share. The deemed dividend increased the net loss applicable to
common stockholders in the calculation of basic and diluted net
loss per common share and was reported as a charge to accumulated
deficit and a credit to additional paid-in capital, with no net
impact on total stockholders&amp;#x2019; equity.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Convertible
Notes&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;At the closing
of the Avigen transaction, we and American Stock
Transfer&amp;#xA0;&amp;amp; Trust Company, LLC, as trustee, entered into
the indenture. Under the terms of a separate trust agreement (the
&amp;#x201C;Trust Agreement&amp;#x201D;), $29.4 million, which represented
the initial principal amount of the Convertible Notes, was
deposited with a trust agent for the benefit of the holders and
us.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Prior to their
maturity on June&amp;#xA0;18, 2011, holders of the Convertible Notes
could submit irrevocable conversion notices instructing the trustee
to convert such Convertible Notes into shares of our common stock
at an initial conversion price of $6.80 per share. Following each
conversion date we would issue the number of whole shares of common
stock issuable upon conversion and the trustee would in turn
release to us the respective amount of restricted cash to cover the
stock issuance. Prior to the maturity of the Convertible Notes,
approximately $1.9 million of the convertible notes were converted
to 276,655 shares of our common stock. All remaining Convertible
Notes matured on June&amp;#xA0;18, 2011 and the principal was repaid in
full.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Firm Underwritten
Public Offering&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
March&amp;#xA0;23, 2011, we consummated a firm-commitment underwritten
public offering of 2,750,000 units at a price to the public of
$3.00 per unit for gross proceeds of $8.25 million. Each unit
consists of one share of common stock, and a warrant to purchase
one share of common stock. The shares of common stock and warrants
are immediately separable and were issued separately. On
March&amp;#xA0;24, 2011, the underwriter exercised 50,666 units of its
412,500 unit overallotment. The warrants are exercisable
immediately upon issuance, have a five-year term and an exercise
price of $3.56 per share. The warrants are indexed to our stock and
do not permit net-cash settlement. On March&amp;#xA0;29, 2011, we
received net proceeds of $7.7 million, after underwriter discount
and underwriter expenses and no warrants exercised. In accordance
with the authoritative guidance, the warrants were classified as
equity instruments as they contain no provisions which may require
cash settlement.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Oxford
Warrant&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In May 2010,
pursuant to the Loan Agreement with Oxford, we issued to Oxford a
warrant to purchase up to 198,020 shares of our common stock at an
exercise price of $6.06 per share. The warrant will terminate on
the earlier of May&amp;#xA0;10, 2017 or the closing date of a merger or
consolidation transaction in which we are not the surviving entity.
In addition, the warrant and debt instrument are immediately
separable and were issued separately. We therefore accounted for
the warrant as a component of stockholders&amp;#x2019; equity as the
agreement requires settlement in shares and under no provision of
the agreement are we required to settle the warrant in
cash.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Kissei Stock
Purchase&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In October
2011, pursuant to a stock purchase agreement by and between us and
Kissei, Kissei purchased for $7.5 million (i)&amp;#xA0;an aggregate of
800,000 shares of our common stock, par value $0.001 per share, at
a price of $2.50 per share, which approximated the fair value of
our common stock at the time of the transaction, and
(ii)&amp;#xA0;220,000 shares of our Series&amp;#xA0;B Convertible Preferred
Stock, or Series B Preferred, par value $0.01 per share, at a price
of $25.00 per share, which approximated the fair value of our
preferred stock on an as converted basis at the time of the
transaction. The purchase agreement contains customary
representations, warranties and covenants and a standstill
agreement from Kissei that terminates if Kissei beneficially owns
less than three percent of our outstanding voting stock. Each share
of the Series B Preferred is convertible into 10&amp;#xA0;shares of
common stock. The Series B Preferred ranks pari passu (on an
as-if-converted-to-common-stock basis) with the common stock in
liquidation and dividend rights. The holders of the Series B
Preferred do not have voting rights, and the consent of a majority
of the outstanding Series B Preferred is required for certain
actions of the Company.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Common Stock Purchase
Agreement&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
August&amp;#xA0;20, 2012, we entered into a common stock purchase
agreement with Aspire pursuant to which the Company may sell to
Aspire, and Aspire would be obligated to purchase, up to an
aggregate of $20 million of our common stock over the two year term
of the agreement including $1 million in common stock purchased by
Aspire in connection with execution of the agreement. Daily sales
of our common stock to Aspire are subject to certain limitations
and the per share sales price is based on closing stock prices at
or near each transaction date. No more than 3,231,096 shares of our
common stock can be issued under this agreement, including the
363,636 shares issued to Aspire in consideration of entering into
the agreement. Our net proceeds will depend on the frequency and
number of shares of our common stock sold to Aspire and the per
share purchase price of each transaction. We may, on any business
day over term of the agreement, direct Aspire to purchase up to
50,000 shares, to a maximum of $500,000 per business day. The
purchase price shall be the lower of the lowest sale price of the
Company&amp;#x2019;s common stock on the date of the sale, or the
average of the three lowest closing stock prices during the 12
consecutive business days ending on the business day immediately
preceding the purchase date. In addition, MediciNova may on any
business day over the term of the Agreement, direct Aspire to make
a volume-weighted average purchase (&amp;#x201C;VWAP&amp;#x201D;) of stock
not to exceed 15% (which limitation may be increased up to 30% by
the mutual agreement of the parties) of the aggregate shares of our
stock traded on the next business day, the purchase price of which
shall be the lower of the closing price on the date of the sale, or
95% of the next business day&amp;#x2019;s Nasdaq volume weighted average
price, subject to a minimum market price threshold established by
us and certain other exceptions. We initially issued 363,636 shares
of our common stock to Aspire as consideration for entering into
the agreement. As of December&amp;#xA0;31, 2012, the Company had
completed sales to Aspire totaling 856,060 shares of common stock
at prices ranging from $1.65 to $1.93 per share, generating gross
proceeds of $1.5 million. Between August&amp;#xA0;21, 2012 and the date
of this report, we have generated proceeds of $3.0 million under
the Common Stock Purchase Agreement with Aspire including proceeds
of $1.5 million on the sale 800,000 shares of our common stock
subsequent to December&amp;#xA0;31, 2012. The agreement with Aspire
provides Aspire certain termination rights, including rights under
an event of default as defined therein, under which the Company may
not require and Aspire would not be obligated to purchase any
shares of our common stock. The Company and Aspire may also not
effect any sales under the agreement on any purchase date where the
closing price of our common stock is less than $1.00 per
share.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Warrant For
Services&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;On
August&amp;#xA0;22, 2012, we issued a warrant in exchange for investor
relations services to purchase up to 130,000 of our common shares
at a price of $1.88 per share, the closing price of our common
stock on that date. The warrant contains provisions whereby the
warrant becomes exercisable for specified shares of our common
stock as a result of our stock achieving certain share price
targets within a 15 month period beginning on August&amp;#xA0;22, 2012.
The warrant expires in five years. The warrant is valued at its
fair value of approximately $100,000 on August&amp;#xA0;22, 2012, is
classified as equity and as a prepaid expense, and is being
amortized over the one year period beginning August&amp;#xA0;22,
2012.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Stock
Options&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;We grant
options to our employees, directors and consultants under our 2004
Plan, the successor to the 2000 Plan.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;2000 General Stock
Incentive Plan&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In September
2000, we adopted the 2000 Plan under which incentive stock options
could be granted to our employees and nonstatutory stock options
and other stock-based awards could be granted to employees,
directors and consultants. Stock options have been granted with an
exercise price of $10.00 per share and vest 25% after the first
year of service from the grant date, with the remaining shares
vesting in equal monthly installments over the subsequent 36 months
of service. An employee may exercise stock options prior to vesting
in which case we have the right to repurchase the unvested shares
at the original exercise price if the employee is terminated before
vesting in all shares occurs.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Following the
vesting period, options are exercisable until the earlier of 90
days after the employee&amp;#x2019;s termination with us or the ten-year
anniversary of the initial grant, subject to adjustment under
certain conditions. We have the right to purchase all of those
shares that the employees have or will acquire under these stock
options. The purchase price for any vested shares repurchased will
be the greater of the fair market value of such shares on the date
of purchase or the aggregate exercise price for such
shares.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;At
December&amp;#xA0;31, 2012, stock options to purchase a total of 4,000
shares of common stock were outstanding under the 2000 Plan at a
weighted average exercise price of $10.00 per share. No additional
stock options have been or will be issued under the 2000 Plan.
However, stock options previously granted under the 2000 Plan will
remain outstanding until the earlier of expiration or
exercise.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;i&gt;2004 Stock Incentive
Plan&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;In connection
with our IPO, we adopted the 2004 Plan, which serves as the
successor program to the 2000 Plan. The 2004 Plan became effective
upon the completion of our IPO in February 2005 and was amended and
restated in February 2007.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The 2004 Plan
is administered by the compensation committee of our board of
directors and provides for the grant of (i)&amp;#xA0;options to
purchase shares of common stock; (ii)&amp;#xA0;restricted stock;
(iii)&amp;#xA0;stock appreciation rights; and (iv)&amp;#xA0;stock units.
Incentive stock options may only be granted to employees.
Nonstatutory stock options and other stock-based awards may be
granted to employees, non-employee directors and
consultants.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The number of
shares reserved for issuance under the 2004 Plan will be increased
on the first day of each of our fiscal years from 2006 through
2014, with the first such increase occurring on January&amp;#xA0;1,
2006, by the lesser of: (i)&amp;#xA0;100,000 shares; (ii)&amp;#xA0;3% of
our outstanding common stock on the last day of the immediately
preceding fiscal year; or (iii)&amp;#xA0;the number of shares
determined by our board of directors. In addition, in February 2007
and June 2008, the total number of shares available for grant under
the 2004 Plan was increased by 300,000 and 1,000,000,
respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"&gt;
&amp;#xA0;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Options granted
to optionees other than non-employee directors will generally vest
monthly over a four-year period, beginning on the vesting
commencement date. The exercise price of an incentive stock option
shall not be less than 100% of the fair market value at the time of
grant and the exercise price of a nonstatutory stock option shall
not be less than 85% of the fair market value at the time of
grant.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The 2004 Plan
terminates ten years after its initial adoption by the board of
directors, unless terminated earlier by the board of directors. The
board of directors may amend or terminate the plan at any time,
subject to stockholder approval where required by applicable
law.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;A summary of
our stock option activity and related information as of
December&amp;#xA0;31, 2012 is as follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"&gt;
&lt;tr&gt;
&lt;td width="67%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Number&amp;#xA0;of&lt;br /&gt;
Option&amp;#xA0;Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;Weighted&amp;#xA0;Average&lt;br /&gt;
Exercise&amp;#xA0;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at
January&amp;#xA0;1, 2012&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,092,671&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;5.52&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Granted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;750,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.01&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(60,000&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2.30&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Cancelled&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;(453,690&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;)&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.57&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Outstanding at
December&amp;#xA0;31, 2012&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,328,981&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;4.92&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Exercisable at
December&amp;#xA0;31, 2012&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;2,089,963&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;6.32&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The weighted
average contractual life of options outstanding at
December&amp;#xA0;31, 2012 was 7.2 years and the weighted average
contractual life of exercisable options at December&amp;#xA0;31, 2012
was 6.1 years. There was no aggregate intrinsic value of stock
options outstanding and options exercisable, during the year ended
December&amp;#xA0;31, 2012.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Common Stock Reserved
for Future Issuance&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"&gt;
&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;The following
table summarizes common stock reserved for future issuance at
December&amp;#xA0;31, 2012:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size="1"&gt;&amp;#xA0;&lt;/font&gt;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="90%" align="center"&gt;
&lt;tr&gt;
&lt;td width="87%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Common Stock under the
employee stock purchase program&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;249,578&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Common stock reserved for
issuance upon exercise of warrant&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,128,686&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Common stock options
outstanding (under the 2000 Plan and 2004 Plan)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;3,328,981&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;Common stock options
authorized for future grant (under the 2004 Plan)&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;466,752&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;7,173,997&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-FAMILY: Times New Roman" size="2"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;
&lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</mnov:StockholdersEquityAndStockBasedCompensationTextBlock>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_497730x544104_513696x501348_629552x629554" unitRef="shares" decimals="0" id="id_1125627_91FFC9CD-8939-485C-8AD5-0E7C93C65A18_3001_5">2019696</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_497730x544104_629552x629554" unitRef="iso4217_USD" decimals="-5" id="id_1125627_91FFC9CD-8939-485C-8AD5-0E7C93C65A18_4001_0">3000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_498752x505060" unitRef="iso4217_USD" decimals="-5" id="id_1125627_A6E08A17-D4AE-4E6C-AC14-BC7764ED5FCF_1001_1">400000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_498752x506779" unitRef="iso4217_USD" decimals="-5" id="id_1125627_A6E08A17-D4AE-4E6C-AC14-BC7764ED5FCF_2001_2">300000</us-gaap:ShareBasedCompensation>
  <mnov:BusinessAcquisitionCostOfAcquiredEntityCashPaidPerShareHeld contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_499577x629064" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_73A85632-5F3A-4766-815B-AD5299EB3892_1002_4">0.04</mnov:BusinessAcquisitionCostOfAcquiredEntityCashPaidPerShareHeld>
  <mnov:BusinessAcquisitionNumberOfConsiderationInstallments contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_499577x629064" unitRef="Increments" decimals="0" id="id_1125627_73A85632-5F3A-4766-815B-AD5299EB3892_1002_5">2</mnov:BusinessAcquisitionNumberOfConsiderationInstallments>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_500742x508125" unitRef="pure" decimals="4" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_1001_6">0.0030</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_500742x508125" unitRef="pure" decimals="2" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_1001_8">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_500742x508125" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_1001_9">P6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_500742x508125" unitRef="pure" decimals="4" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_1001_7">0.7950</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_500849x506554" unitRef="pure" decimals="4" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_2001_1">0.0067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_500849x506554" unitRef="pure" decimals="2" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_2001_3">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_500849x506554" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_2001_4">P5Y3M22D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_500849x506554" unitRef="pure" decimals="4" id="id_1125627_351D9EF8-BE00-4FBF-8880-BC7D0C26FE9C_2001_2">0.8326</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x500724" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38007_1000127">-11112</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38003_600121">60000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38003_700123">1219</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x501348" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38003_700121">60</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x501348" unitRef="shares" decimals="INF" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38003_600123">1219696</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x502884" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38008_1100122">58619</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x503287" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38009_1200126">-10961314</us-gaap:NetIncomeLoss>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38005_800124">100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38005_800123">1347654</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38005_800121">137670</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x508619" unitRef="iso4217_USD" decimals="0" id="id_1125627_5E3EB396-7357-42A7-9C23-EAAEEC1A8D9C_38005_800120">709650</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <mnov:OperatingLossCarryforwardsExpirationYear contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_508681x532681" id="id_1125627_1F055DDA-8FA7-4AD5-8091-C582F63323EE_1002_4">2020</mnov:OperatingLossCarryforwardsExpirationYear>
  <mnov:ResearchAndDevelopmentCreditsExpirationYear contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_508681x532681" id="id_1125627_1F055DDA-8FA7-4AD5-8091-C582F63323EE_1002_6">2024</mnov:ResearchAndDevelopmentCreditsExpirationYear>
  <mnov:OperatingLossCarryforwardsExpirationYear contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_508681x534951" id="id_1125627_1F055DDA-8FA7-4AD5-8091-C582F63323EE_2002_5">2013</mnov:OperatingLossCarryforwardsExpirationYear>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_510903x500372" id="id_1125627_EE48C342-11A9-4572-A205-12748F98EB1A_1001_0">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_510903x504035" id="id_1125627_EE48C342-11A9-4572-A205-12748F98EB1A_2001_1">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_510903x506627" id="id_1125627_EE48C342-11A9-4572-A205-12748F98EB1A_3001_2">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_510903x513379" id="id_1125627_EE48C342-11A9-4572-A205-12748F98EB1A_4001_3">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_511283x507958" unitRef="pure" decimals="4" id="id_1125627_64B758A5-DA4C-4FA6-ADA9-EE90E668106E_1001_0">0.0286</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_511283x507958" unitRef="pure" decimals="INF" id="id_1125627_64B758A5-DA4C-4FA6-ADA9-EE90E668106E_1001_2">0</us-gaap:FairValueAssumptionsExpectedDividendRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_511283x507958" unitRef="pure" decimals="2" id="id_1125627_64B758A5-DA4C-4FA6-ADA9-EE90E668106E_1001_1">0.76</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsExpectedTerm contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_511283x507958" id="id_1125627_64B758A5-DA4C-4FA6-ADA9-EE90E668106E_1001_3">P7Y</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_513696x501348" unitRef="shares" decimals="INF" id="id_1125627_A6E08A17-D4AE-4E6C-AC14-BC7764ED5FCF_3001_3">60000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_514791x503547" unitRef="shares" decimals="INF" id="id_1125627_160FA594-AA0F-4D8E-8EAA-6C75ED1CC0AE_1001_0">2200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_514791x507958" unitRef="shares" decimals="INF" id="id_1125627_160FA594-AA0F-4D8E-8EAA-6C75ED1CC0AE_2001_2">3128686</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE402953--1210-K0005_STD_366_20121231_0_514791x514283" unitRef="shares" decimals="INF" id="id_1125627_160FA594-AA0F-4D8E-8EAA-6C75ED1CC0AE_3001_1">3328981</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:PaymentsToAcquireInvestments contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_19">377205766</us-gaap:PaymentsToAcquireInvestments>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_6">-278209637</us-gaap:OperatingIncomeLoss>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_26">132665225</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_18">2829785</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:GainLossOnDispositionOfAssets contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_8">-11460</us-gaap:GainLossOnDispositionOfAssets>
  <us-gaap:PaymentsToAcquireInterestInJointVenture contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_22">680000</us-gaap:PaymentsToAcquireInterestInJointVenture>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_5">2014052</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_3">50390931</us-gaap:ShareBasedCompensation>
  <us-gaap:IncreaseDecreaseOfRestrictedInvestments contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_14">-5982</us-gaap:IncreaseDecreaseOfRestrictedInvestments>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_23">256845</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_31">1164868</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_16">-209712471</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_24">-4901434</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:IncomeTaxesPaid contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_43">69601</us-gaap:IncomeTaxesPaid>
  <us-gaap:OtherNonoperatingExpense contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_8">389230</us-gaap:OtherNonoperatingExpense>
  <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_15">2500000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:ProceedsFromIssuanceOfDebt contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_29">14670000</us-gaap:ProceedsFromIssuanceOfDebt>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_21">2360968</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_35">4010530</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_13">131983</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_4">112257368</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_11">310664</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:OtherNonoperatingIncome contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_10">19145183</us-gaap:OtherNonoperatingIncome>
  <us-gaap:UnrealizedGainLossOnInvestments contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_7">-1735212</us-gaap:UnrealizedGainLossOnInvestments>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_21">-67957</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_3">167054655</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_34">218624435</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:CostOfRevenue contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_2">1258421</us-gaap:CostOfRevenue>
  <us-gaap:OperatingExpenses contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_5">280570444</us-gaap:OperatingExpenses>
  <us-gaap:RepaymentsOfDebt contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_32">15000000</us-gaap:RepaymentsOfDebt>
  <us-gaap:OperatingLeasesRentExpenseNet contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="-5" id="id_1125627_2AA75423-F9FE-4E73-B9CE-71D153C7A917_8_6">5000000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:Revenues contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_0">2360807</us-gaap:Revenues>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="INF" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_11">-264794714</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:ConversionOfStockAmountConverted1 contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="INF" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_40">43515677</us-gaap:ConversionOfStockAmountConverted1>
  <us-gaap:InterestPaid contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_44">2487343</us-gaap:InterestPaid>
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_20">377918240</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_13">-264870675</us-gaap:NetIncomeLoss>
  <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="INF" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_14">98445</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_12">75961</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_16">-296233797</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_22">-296301754</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_27">85572825</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_946EBB50-9ECD-45E2-9C56-59705EF272AE_3_0">1196091</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
  <us-gaap:InterestExpense contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_9">3605818</us-gaap:InterestExpense>
  <mnov:IssuanceOfWarrants contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_39">2882258</mnov:IssuanceOfWarrants>
  <mnov:NumberOfLicenses contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="Agreement" decimals="INF" id="id_1125627_AACC2653-5A4A-44FF-939F-27DE22182954_1_0">8</mnov:NumberOfLicenses>
  <mnov:AmortizationOfDeferredRevenue contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_4">1697420</mnov:AmortizationOfDeferredRevenue>
  <mnov:AmortizationOfPremiumDiscountOnInvestmentSecuritiesConvertibleNotesAndDebtDiscountAndIssuanceCosts contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_6">1099365</mnov:AmortizationOfPremiumDiscountOnInvestmentSecuritiesConvertibleNotesAndDebtDiscountAndIssuanceCosts>
  <mnov:DeemedDividendResultingFromConvertiblePreferredStock contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F4F1BBEA-5ABB-4CEF-AB4C-30649131D8C6_3_15">31264677</mnov:DeemedDividendResultingFromConvertiblePreferredStock>
  <mnov:ImpairmentChargeGainNetOnInvestmentSecuritiesAndArsPut contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_7">-1735212</mnov:ImpairmentChargeGainNetOnInvestmentSecuritiesAndArsPut>
  <mnov:ImpairmentOfSublease contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_9">35259</mnov:ImpairmentOfSublease>
  <mnov:IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_12">545034</mnov:IncreaseDecreaseInAccountsPayableAccruedExpensesIncomeTaxesPayableAndDeferredRent>
  <mnov:ProceedsFromArsLoan contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_28">17605485</mnov:ProceedsFromArsLoan>
  <mnov:ProceedsFromConversionOfConvertibleNotes contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_30">1881253</mnov:ProceedsFromConversionOfConvertibleNotes>
  <mnov:RepaymentsOfArsLoan contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_33">17605485</mnov:RepaymentsOfArsLoan>
  <mnov:RestrictedAssetsCashUnrestrictedUponConversionOfConvertibleNotes contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_1125627_F1E92A19-AA45-47A4-ADB1-A17A33A3F023_3_41">1881815</mnov:RestrictedAssetsCashUnrestrictedUponConversionOfConvertibleNotes>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE402953--1210-K0005_STD_4475_20121231_0_501050x510280" unitRef="iso4217_USD" decimals="0" id="id_1125627_0C761BC2-ECC9-4F76-B32B-34BD2F5F318D_1001_0">9850000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE402953--1210-K0005_STD_90_20050331_0_501891x497548_512768x505027" unitRef="iso4217_USD" decimals="0" id="id_1125627_3E6AB2D5-1341-4F61-B8F7-8211FCEFB0E7_1001_1">104486895</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE402953--1210-K0005_STD_90_20050331_0_501891x497548_512768x505027" unitRef="shares" decimals="INF" id="id_1125627_3E6AB2D5-1341-4F61-B8F7-8211FCEFB0E7_1001_0">3000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE402953--1210-K0005_STD_90_20110331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_1_3">-0.45</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:OperatingExpenses contextRef="eol_PE402953--1210-K0005_STD_90_20110331_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_1_0">4976000</us-gaap:OperatingExpenses>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_90_20110331_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_1_1">-5656000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE402953--1210-K0005_STD_90_20110331_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_1_2">-5656000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE402953--1210-K0005_STD_91_20120331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_1_4">-0.24</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:OperatingExpenses contextRef="eol_PE402953--1210-K0005_STD_91_20120331_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_1_1">4064000</us-gaap:OperatingExpenses>
  <us-gaap:Revenues contextRef="eol_PE402953--1210-K0005_STD_91_20120331_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_1_0">191000</us-gaap:Revenues>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_91_20120331_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_1_2">-3867000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE402953--1210-K0005_STD_91_20120331_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_1_3">-3867000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE402953--1210-K0005_STD_91_20120630_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_2_4">-0.14</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:OperatingExpenses contextRef="eol_PE402953--1210-K0005_STD_91_20120630_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_2_1">2781000</us-gaap:OperatingExpenses>
  <us-gaap:Revenues contextRef="eol_PE402953--1210-K0005_STD_91_20120630_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_2_0">494000</us-gaap:Revenues>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_91_20120630_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_2_2">-2281000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE402953--1210-K0005_STD_91_20120630_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_2_3">-2281000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE402953--1210-K0005_STD_91_20110630_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_2_3">-0.31</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:OperatingExpenses contextRef="eol_PE402953--1210-K0005_STD_91_20110630_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_2_0">3722000</us-gaap:OperatingExpenses>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_91_20110630_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_2_1">-4681000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE402953--1210-K0005_STD_91_20110630_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_2_2">-4681000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE402953--1210-K0005_STD_92_20110930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_3_3">-0.25</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:OperatingExpenses contextRef="eol_PE402953--1210-K0005_STD_92_20110930_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_3_0">3907000</us-gaap:OperatingExpenses>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_92_20110930_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_3_1">-3894000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE402953--1210-K0005_STD_92_20110930_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_3_2">-3894000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE402953--1210-K0005_STD_92_20120930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_3_4">-0.14</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:OperatingExpenses contextRef="eol_PE402953--1210-K0005_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_3_1">2446000</us-gaap:OperatingExpenses>
  <us-gaap:Revenues contextRef="eol_PE402953--1210-K0005_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_3_0">84000</us-gaap:Revenues>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_3_2">-2379000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE402953--1210-K0005_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_3_3">-2379000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE402953--1210-K0005_STD_92_20111231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_4_3">-0.22</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:OperatingExpenses contextRef="eol_PE402953--1210-K0005_STD_92_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_4_0">3503000</us-gaap:OperatingExpenses>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_92_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_4_1">-3503000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE402953--1210-K0005_STD_92_20111231_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_4_2">-3503000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE402953--1210-K0005_STD_92_20121231_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_4_4">-0.14</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:OperatingExpenses contextRef="eol_PE402953--1210-K0005_STD_92_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_4_1">2455000</us-gaap:OperatingExpenses>
  <us-gaap:Revenues contextRef="eol_PE402953--1210-K0005_STD_92_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_4_0">34000</us-gaap:Revenues>
  <us-gaap:NetIncomeLoss contextRef="eol_PE402953--1210-K0005_STD_92_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_4_2">-2434000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE402953--1210-K0005_STD_92_20121231_0" unitRef="iso4217_USD" decimals="-3" id="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_4_3">-2434000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <context id="eol_PE402953--1210-K0005_STD_92_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_92_20111231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_92_20120930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2012-07-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_92_20110930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2011-07-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_91_20110630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2011-04-01</startDate>
      <endDate>2011-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_91_20120630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2012-04-01</startDate>
      <endDate>2012-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_91_20120331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_90_20110331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_90_20050331_0_501891x497548_512768x505027">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:JP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_4475_20121231_0_501050x510280">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-10-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_4475_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2000-10-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_514791x514283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_514791x507958">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_514791x503547">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_513696x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_511283x507958">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_510903x513379">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_510903x506627">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_510903x504035">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_510903x500372">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_508681x534951">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">mnov:CaliforniaMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_508681x532681">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">mnov:FederalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_500849x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_500742x508125">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_499577x629064">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnov:AvigenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_498752x506779">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_498752x505060">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_497730x544104_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:AspireCapitalFundLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0_497730x544104_513696x501348_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:AspireCapitalFundLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20081231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20081231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20081231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20081231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20081231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20041231_0_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x508619_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x508619_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x508051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x503547_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x503287_513696x501142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20041231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20041231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20001231_0_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-01-01</startDate>
      <endDate>2000-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20001231_0_505872x508619_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-01-01</startDate>
      <endDate>2000-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20001231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-01-01</startDate>
      <endDate>2000-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20001231_0_505872x503547_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-01-01</startDate>
      <endDate>2000-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20001231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-01-01</startDate>
      <endDate>2000-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20001231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2000-01-01</startDate>
      <endDate>2000-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_366_20001231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2000-01-01</startDate>
      <endDate>2000-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_514791x514283">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_514791x507958">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_514791x503547">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_513696x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_507189x534959">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">mnov:CommonStockAndWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x508619_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x508619_507189x534959">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">mnov:CommonStockAndWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x503547_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x501348_507189x534959">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">mnov:CommonStockAndWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_500849x506554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_500742x508125">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_498752x506779">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_498752x505060">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x678600_511283x507958">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mnov:ContraLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x678600_503845x532020">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mnov:ContraLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnov:DebtIssuanceCostsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x678600">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mnov:ContraLiabilityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x534321">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mnov:OtherAssetMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x503003_503845x598913">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnov:DeferredChargesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x503003_503845x507708">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LoansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0_497966x503003">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20111231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20110331_0_499577x629064_508454x644458">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnov:ProRataShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnov:AvigenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-01</startDate>
      <endDate>2011-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20071231_0_512768x509009">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20071231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20071231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20071231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20071231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20071231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20071231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x508051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20061231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20061231_0_504957x514053">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20061231_0_504957x513639">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20061231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20051231_0_512768x505027">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x508619_512768x505027">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x508051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x503547">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x501348_512768x505027">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20051231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20051231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20031231_0_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20031231_0_505872x508619_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20031231_0_505872x503547_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20031231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20031231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20021231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20021231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20011231_0_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20011231_0_505872x508619_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20011231_0_505872x503547_513696x498640">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20011231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20011231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2001-01-01</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20101231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20101231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20091231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20091231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20091231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20091231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20091231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_365_20091231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20121231_0_497730x544104_505872x501348_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:AspireCapitalFundLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-12-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20121231_0_497730x544104_504957x514053_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:AspireCapitalFundLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-12-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20121231_0_497730x544104_504957x514053_505872x501348_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:AspireCapitalFundLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-12-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20121231_0_497730x544104_504957x513639_505872x501348_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:AspireCapitalFundLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-12-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20110331_0_499577x629064">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnov:AvigenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-03-01</startDate>
      <endDate>2011-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20110331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2011-03-01</startDate>
      <endDate>2011-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20120831_0_497730x544104_513696x501348_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:AspireCapitalFundLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-08-01</startDate>
      <endDate>2012-08-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20120831_0_497730x544104_505872x501348_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:AspireCapitalFundLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-08-01</startDate>
      <endDate>2012-08-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20120831_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2012-08-01</startDate>
      <endDate>2012-08-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20111031_0_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20111031_0_513696x511225_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20111031_0_513696x511225">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20111031_0_505872x501348_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20111031_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20111031_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20091231_0_499577x629064">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnov:AvigenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-12-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20110731_0_501891x543711">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mnov:SanDiegoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-07-01</startDate>
      <endDate>2011-07-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20100531_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2010-05-01</startDate>
      <endDate>2010-05-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20130331_0_497730x544104_506663x510886_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:AspireCapitalFundLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:IssuanceOfEquityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-03-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20130331_0_497730x544104_506663x510886_513696x501348_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:AspireCapitalFundLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:IssuanceOfEquityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-03-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20130331_0_497730x544104_505872x501348_506663x510886_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:AspireCapitalFundLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:IssuanceOfEquityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-03-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20120331_0_501891x543711">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mnov:SanDiegoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-03-01</startDate>
      <endDate>2012-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20120331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2012-03-01</startDate>
      <endDate>2012-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_31_20050331_0_501891x497548_512768x586108">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:JP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mnov:UnderwritersOverallotmentOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-03-01</startDate>
      <endDate>2005-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_30_20000930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2000-09-01</startDate>
      <endDate>2000-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_30_20080630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2008-06-01</startDate>
      <endDate>2008-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_30_20050630_0_501891x497548">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-06-01</startDate>
      <endDate>2005-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_28_20040930_0_513696x506792">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2004-09-03</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_28_20130228_0_506663x533051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">mnov:SubleaseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-02-01</startDate>
      <endDate>2013-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_27_20070228_0_501891x497488_512768x505027">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-02-02</startDate>
      <endDate>2007-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_27_20070228_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2007-02-02</startDate>
      <endDate>2007-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_20_20050228_0_508454x536875">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnov:NonstatutoryStockOptionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-02-09</startDate>
      <endDate>2005-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_20_20050228_0_508454x533445">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnov:IncentiveStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-02-09</startDate>
      <endDate>2005-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_20_20050228_0_501891x497548_512768x505027">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:JP</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-02-09</startDate>
      <endDate>2005-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_20_20050228_0_501891x497548">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-02-09</startDate>
      <endDate>2005-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_20_20050228_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <startDate>2005-02-09</startDate>
      <endDate>2005-02-28</endDate>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_512768x509009">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_511283x507958">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_509470x506023">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_508681x534951">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">mnov:CaliforniaMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_508681x532681">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">mnov:FederalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_508454x517939">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mnov:StockPlanTwentyZeroFourMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_508454x511626">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_505872x503547">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_505769x507958">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_501050x510280">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_498503x502717_510142x508799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_498503x502717">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_498429x586825">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mnov:TwoThousandPlanMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_497966x514038">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ProfessionalFeesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_497966x506779">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0_497966x504935">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20111231_0_507189x534959">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">mnov:CommonStockAndWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20111231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20111231_0_505872x503547">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20111231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20111231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20111231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20111231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20111231_0_498503x502717_510142x508799">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20111231_0_498503x502717">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20111231_0_497966x629304">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mnov:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20111231_0_497966x514038">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ProfessionalFeesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20111231_0_497966x506779">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20111231_0_497966x504935">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20111231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20110331_0_499577x629064">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnov:AvigenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-03-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20110331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2011-03-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20110324_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2011-03-24</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20110323_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2011-03-23</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20081231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20081231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20081231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20081231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20081231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20081231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20071231_0_512768x509009">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20071231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20071231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20071231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20071231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20071231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20071231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20061231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20061231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20061231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20061231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20061231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20061231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20051231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20051231_0_505872x508051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20051231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20051231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20051231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20051231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20051231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20041231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20041231_0_505872x508051">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20041231_0_505872x503547">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20041231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20041231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20041231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20031231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20031231_0_505872x503547">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20031231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20031231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20031231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20021231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20021231_0_505872x503547">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20021231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20021231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20021231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20011231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20011231_0_505872x503547">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20011231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20011231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20011231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20001231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2000-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20001231_0_505872x503547">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2000-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20001231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2000-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20001231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2000-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20001231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2000-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20120831_0_497730x544104_505872x501348_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:AspireCapitalFundLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-08-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20120831_0_497730x544104_504957x514053_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:AspireCapitalFundLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-08-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20120831_0_497730x544104_504957x514053_505872x501348_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:AspireCapitalFundLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-08-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20120831_0_497730x544104_504957x514053_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:AspireCapitalFundLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-08-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20120831_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2012-08-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20111031_0_629552x629554">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="mnov:SharePurchaseAgreementAxis">mnov:SharePurchaseAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-10-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20101231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20101231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20101231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20101231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20101231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20101231_0_497966x678600_511283x507958">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mnov:ContraLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20101231_0_497966x678600_503845x532020">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mnov:ContraLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnov:DebtIssuanceCostsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20101231_0_497966x678600">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mnov:ContraLiabilityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20101231_0_497966x534321">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mnov:OtherAssetMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20101231_0_497966x503003_503845x598913">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mnov:DeferredChargesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20101231_0_497966x503003_503845x507708">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LoansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20101231_0_497966x503003">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20101231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20091231_0_505872x508619">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20091231_0_505872x503287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20091231_0_505872x502884">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20091231_0_505872x501348">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20091231_0_505872x500724">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20091231_0_499577x629064">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mnov:AvigenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20091231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20040902_0_513696x506792">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-09-02</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20000930_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2000-09-30</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20120629_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2012-06-29</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20110618_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2011-06-18</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20100531_0_497730x629508_501883x507828">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:RedingtonMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareholdersEquityClassAxis">us-gaap:WarrantsNotSettleableInCashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-05-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20100531_0_497730x537055_501883x507828">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mnov:OxfordLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareholdersEquityClassAxis">us-gaap:WarrantsNotSettleableInCashMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-05-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20100531_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2010-05-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20130327_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2013-03-27</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20120331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2012-03-31</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20120822_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2012-08-22</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20110505_0_514782x597451">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mnov:AtMarketIssuanceSalesAgreementMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-05-05</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20070201_0_501891x497488_512768x505027">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2007-02-01</instant>
    </period>
  </context>
  <context id="eol_PE402953--1210-K0005_STD_0_20050228_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001226616</identifier>
    </entity>
    <period>
      <instant>2005-02-28</instant>
    </period>
  </context>
  <unit id="pure">
    <measure>pure</measure>
  </unit>
  <unit id="shares">
    <measure>shares</measure>
  </unit>
  <unit id="iso4217_USD_per_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="iso4217_USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="iso4217_USD_per_Right">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>mnov:Right</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="M">
    <measure>utr:M</measure>
  </unit>
  <unit id="Segment">
    <measure>mnov:Segment</measure>
  </unit>
  <unit id="Increments">
    <measure>mnov:Increments</measure>
  </unit>
  <unit id="Agreement">
    <measure>mnov:Agreement</measure>
  </unit>
  <xbrll:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <xbrll:loc xlink:href="#id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_1_3" xlink:label="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_1_3" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_2_3" xlink:label="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_2_3" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_3_3" xlink:label="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_3_3" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_4_3" xlink:label="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_4_3" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_1_4" xlink:label="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_1_4" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_2_4" xlink:label="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_2_4" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_3_4" xlink:label="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_3_4" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_4_4" xlink:label="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_4_4" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_1001_1" xlink:label="id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_1001_1" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_4001_2" xlink:label="id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_4001_2" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_4001_3" xlink:label="id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_4001_3" xlink:type="locator"/>
    <xbrll:footnote xlink:label="footnote_105164577" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The relative fair value of the warrants issued to the lender was calculated using a Black-Scholes valuation model. The risk-free interest rate assumption was 2.86 percent based upon observed risk-free interest rates appropriate for the expected term of the warrants. The expected volatility assumption was 76 percent consistent with the volatility of our common stock based on the historical volatility of our stock since listing on the Nasdaq Global Market in December 2006. We have not paid and do not anticipate paying dividends on our common stock since our inception, and therefore, the dividend yield assumption was zero. The expected term assumption was seven years, which is the contractual life of the warrants. The fair value of the warrants using the Black-Scholes valuation model was calculated to be $4.34 per share.</xbrll:footnote>
    <xbrll:footnote xlink:label="footnote_105164582" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Loss per share is computed independently for each of the quarters presented. The sum of the quarterly net loss per share will not necessarily equal the total for the year.</xbrll:footnote>
    <xbrll:footnoteArc xlink:from="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_1_3" xlink:to="footnote_105164582" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_2_3" xlink:to="footnote_105164582" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_3_3" xlink:to="footnote_105164582" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_1125627_AD4A9D34-27C1-4B7C-9B2F-444DCF425AF4_4_3" xlink:to="footnote_105164582" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_1_4" xlink:to="footnote_105164582" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_2_4" xlink:to="footnote_105164582" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_3_4" xlink:to="footnote_105164582" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_1125627_CE425BD7-79F5-40A2-82FD-0C8C0EC69DBC_4_4" xlink:to="footnote_105164582" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_1001_1" xlink:to="footnote_105164577" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_4001_2" xlink:to="footnote_105164577" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_1125627_D496E0C6-0A1B-43D9-8AE8-9F9E5A2064D5_4001_3" xlink:to="footnote_105164577" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
  </xbrll:footnoteLink>
</xbrl>





